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ABSTRACT
SUMOylation is an Ubiquitin-like post-translational modification thought to affect a 
diverse array of cellular processes, from chromosome segregation to nuclear transloca­
tion. The El SUMO-activating enzyme is required for the earliest steps of SUMO con­
jugation, and is composed of heterodimeric Aosl and Uba2 subunits. The genes 
encoding both of these proteins are essential for viability in yeast, but less is known 
about their biological role in other organisms. Here we report a transposable element 
mutation in the aosl gene of Drosophila that causes complete elimination of imaginal 
discs (appendage primordia) in homozygous larvae, while the rest of larval tissues ap­
pear to be unaffected. We were able to rescue this growth phenotype with a genomic 
construct containing only the aosl gene, confirming that the growth defect results 
solely from loss of aosl. Mosaic analysis reveals that aosl mutant disc cells die 
through apoptosis, but when apoptosis is blocked the mutant cells exhibit cell cycle 
progression defects. Using FACS analysis to measure cell cycle phasing, we found that 
aosl mutant cells accumulate in G2/M, indicating a blockage in progression to mitosis. 
Additionally, uba2 homozygous mutant animals also lack imaginal discs without ex­
hibiting defects in larval tissues, indicating that SUMO El enzyme activity is require- 
red more in some cells than in others. Consistent with this, we show that aosl and uba2 
are primarily required for cell proliferation, since RNAi-mediated aosl and uba2 
knockdown in dividing cells of the eye discs resulted in reduction of eye size, while 
expression of aosl or uba2 RNAi in post-mitotic cells of the eye disc had no effect. 
Together, these results reveal a key role for the El SUMO activating enzyme in cell 
proliferation, but they suggest that SUMO El activity is less required for cellular sur­
vival, differentiation, or homeostasis of non-dividing cells.
Table of Contents
Table of Figures.......................................................................................................................................... 4
Table of Tables............................................................................................................................................ 5
Abbreviations.............................................................................................................................................. 6
INTRODUCTION...................................................................................................................................... 8
Chapter 1 .................................................................................................................................................9
Development of Drosophila melanogaster.........................................................................................9
Life Cycle o f Drosophila................................................................................................................10
Embryogenesis and Larval development-Cell Division and Growth.......................................11
Cell cycle progression.................................................................................................................... 12
Cell cycle modulation in different developmental stages o f Drosophila................................ 15
Imaginal discs-growth and patterning........................................................................................ 16
Pupa formation-Ecdysone.............................................................................................................18
Imaginal disc growth defects observed in mutation o f a SUMOylation pathway enzyme... 19
Chapter 2 .............................................................................................................................................. 21
SUMOylation........................................................................................................................................21
SUMO (Small Ubiquitin-related Modifier)................................................................................ 21
SUMO conjugation pathway ........................................................................................................22
SUMOl and SUM02/3 isoforms and SUMO chains............................................................... 25
The E l SUMO activating enzyme (Aosl/Uba2).........................................................................27
The E2 SUMO conjugation enzyme (Ubc9)............................................................................... 29
E3 SUMO Ligases.......................................................................................................................... 29
SUMO Deconjugation Enzymes (Ulp/SENPs)........................................................................... 31
SUMOylation and downstream effectors (SIMproteins).........................................................33
Regulation o f SUMOylation......................................................................................................... 34
Functions o f SUMOylation.......................................................................................................... 36
SUMOylation and development....................................................................................................41
SUMOylation in growth and patterning o f Drosophila............................................................ 42
METHODS AND MATERIALS........................................................................................................... 45
Fly strains.................... 45
Mosaic analysis.............................................................................................................................. 46
Plasmid construction.....................................................................................................................47
In situ hybridization in larvae using RNA probe (Patelprotocol)...........................................49
Protein extraction from larvae and Western blot analysis.......................................................51
Immunostaining............................................................................................................................. 52
Imaginal disc cell preparation for FACS....................................................................................53
dsRNA knock-down in S2 cells.....................................................................................................54
RESULTS...................................................................................................................................................56
Chapter 1 .............................................................................................................................................. 57
Analysis of the aosl17744 allele and generation of additional alleles...........................................57
The aosl17744 mutation...................................................................................................................57
Phenotypic description o f the aosl17744 mutants........................................................................58
Rescue experiments confirm aosl17744 to be an aosl allele......................................................60
aosl is broadly expressed, but at variable levels in different tissues.......................................61
aosl transcription is detected in aosl17744 mutant larvae..........................................................63
Identification o f new aosl alleles by TILLing........................................................................... 65
Generation o f aosl null alleles by homologous recombination (Golic method)................... 66
aosl null alleles are obtained with homologous recombination (Golic method).................. 68
Chapter 2 .............................................................................................................................................. 72
Generation of uba2 alleles and double aosl, uba2 mutant..........................................................72
animals.72
Generation o f new uba2 alleles with imprecise P-element excision........................................73
Molecular characterization o f the uba2C3 and uba2m alleles..................................................74
Generation o f double aosl, uba2 mutant animals.....................................................................75
Global SUMOylation is severely reduced /  eliminated in the mutant animals......................76
Chapter 3 .............................................................................................................................................. 79
Phenotypic analysis of aosl and uba2 mutant cells in the imaginal discs................................ 79
Mosaic analysis o f aosl and uba2 mutant mitotic clones indicates that mutant imaginal
disc cells die through apoptosis....................................................................................................80
Expression o f the p35 Caspase inhibitor in aosl17744 mutant disc cells reveals more mutant
2
phenotypes......................................................................................................................................82
p 35-expressing aosl17744 mutant clones exhibit cell cycle progression defects.......................85
Induction o f aosl17744 mutant clones in Minute background could not rescue the lethality
of mutant cells.................................................................................................................................87
Cyclin A and Cyclin B are stabilized in p 35-expressing aosl17744 mutant clones.................. 88
SUMOylation pathway components are required in dividing but not differentiated imaginal
disc cells .......................................................................................................................................... 91
Chapter 4 .............................................................................................................................................. 94
Cell cycle profile analysis in S2 cells upon aosl knock down with dsRNA.............................. 94
aosl knockdown in S2 cells eliminates Aosl protein but does not affect cell cycle
progression...................................................................................................................................... 95
smt3 (SUMO) knockdown in S2 cells eliminated SUMO protein and caused cell cycle 
progression defects in more than one phase .............................................................................. 96
DISCUSSION............................................................................................................................................ 99
SUMOylation and development..................................................................................................100
SUMOylation and cell cycle progression ........................................................................... 101
SUMOylation is required for dividing cells but it is probably dispensable for viability o f 
non-dividing cells......................................................................................................................... 103
REFERENCES  .......................................................................................................................... 108
Table of Figures
Figure 1. Life Cycle of Drosophila melanogaster........................................................ 10
Figure 2. Cell cycle phases and the Cdk-Cyclin complexes that control the progression 
through them...................................................................................................................13
Figure 3. Imaginal discs in Drosophila that give rise to the adult tissues during meta­
morpho­
sis.............................................................................................................................16
Figure 4. SUMO conjugation pathway......................................................................... 23
Figure 5. The domains of human Aosl/Sael and Uba2/Sael El subunits................. 27
Figure 6. In aosl17744 mutant larvae, imaginal discs and optic lobes of CNS are ab­
sent..................................................................................................................................58
Figure 7. Rescues experiments confirmed aosl17744 mutation as an aosl al­
lele.................................................................................................................................. 60
Figure 8. In situ hybridization shows the aosl expression...........................................62
Figure 9. aosl transcript can be detected in aosl17744 mutant animals with RT- 
PCR.................................................................................................................................63
Figure 10. aoslGollc1'2 and aosl17744 mutant animals exhibited similar pheno­
types................................................................................................................................69
Figure 11. The Aosl protein levels in the aosl mutant animals are monitored by west­
ern blot analysis..............................................................................................................70
Figure 12. The uba2 gene model.................................................................................. 72
Figure 13. The uba2 transcript and protein levels in uba2 mutant animals were moni­
tored with RT-PCR and Western blot analysis respectively.........................................74
Figure 14. Western blot analysis showed that global SUMOylation in all mutants is 
severely reduced............................................................................................................ 76
Figure 15. aosl17744 mutant mitotic clones die through apop­
tosis.................................79
Figure 16. uha2m  mutant mitotic clones die through apoptosis similarly with the 
aosl17744 mutant clones.................................................................................................. 80
Figure 17. p35 expression in aosl17744 mutant clones reveals morphological defects in 
the mutant cells.............................................................................................................. 81
Figure 18. p3 5-expressing aosl17744 mutant clones gradually extrude from the epithe­
lium.................................................................................................................................83
4
Figure 19. p3 5-expressing aosl17744 mutant clone cells accumulate at the 
G2/M 85
Figure 20. wild type and aosl17744 mutant clones in Minute/+ genetic back­
ground.............................................................................................................................87
Figure 21. Cyclins A and B are stabilized in p3 5-expressing aosl17744 mutant clone 
cells.................................................................................................................................89
Figure 22. RNAi knock down of the SUMOylation pathway components in the eye 
imaginal discs.................................................................................................................92
Figure 23. Aosl knock down in S2 cells...................................................................... 95
Figure 24. Smt3 knock down in S2 cells...................................................................... 97
Table of Tables
Table 1. aosl mutations that were identified by Tilling 65
Abbreviations
AP axis Anterior-Posterior axis
APC Anaphase Promoting Complex
BDGP Berkeley Drosophila Genome Project
Cdk Cyclin-Dependent Kinase
CNS Central Nervous System
dsRNA Double stranded RNA
DV axis Dorso-Ventral axis
EMS Ethyl Methane-Sulphonate
EtOH Ethanol
FACS Fluorescence Activated Cell Sorting
FLP Flippase Recognition Target
GFP Green Fluorescent Protein
hs Heat Shock
JH Juvenile hormone
MARCM Mosaic Analysis with a Repressible Cell Marker
ME Methanol
NEM V-Ethylmaleimide1
PBac PiggyBac
PFA Paraformaldehyde
PMSF Phenylmethylsulfonyl Fluoride
PTTH Prothoracicotropic Hormone
RFP Red Florescent Protein
RT Room Temperature
6
RT-PCR Reverse Transcription Polymerase Chain Reaction
SAGE Serial Analysis of Gene Expression
SDS-PAGE Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis
SIM SUMO Interacting Motif
SUMO Small Ubiquitin-related Modifier
UAS Upstream Activation Sequence
UTR Untranslated Region
7
Chapter 1 
Development of Drosophila melanogaster
Life Cycle of Drosophila
Drosophila melanogaster, under normal laboratory conditions (growth at 25° C), 
completes its life cycle in about 10 days (Fig 1). Initially fertilized eggs are laid by the 
female after mating. The process of embryogenesis lasts for 22-24 hours. The larvae 
hatch after the end of embryonic development and start feeding. There are three larval 
stages, referred to as instars. The first and the second larval instars last for 24 hour, 
while the third lasts for approximately 48 hours, dependent on nutritional conditions 
and crowding. The termination of the first and second larval instars is followed by 
molting to the next stage, whereas the end of the third larval stage is followed by pupa 
formation. During the pupal development of Drosophila and other holometabolous in­
sects, the animal undergoes metamorphosis and the body is completely reformed. The 
adults flies eclose from their pupal case after 4-4.5 days (Ashbumer et al., 2005).
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The life cycle of Drosophila melanogaster
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Figure 1
Life Cycle o f Drosophila melanogaster. Upon completion of embryogenesis, animals pass through 
three larval instar stages. At the end of larval development, a pupa is formed. Metamorphosis takes 
place during pupa stage and the adult flies eclose from the pupa after -4 .5  days.
Embryogenesis and Larval development-Cell Division and Growth
Upon egg fertilization rapid divisions take place. The first 13 cycles of nuclear divi­
sion that are not followed by cytokinesis and the thus the nuclei share the same cyto- 
plasm-syncytium (Foe et al., 1993). At the 9th division cycle, most of the nuclei move 
to the periphery of the embryo. 5-10 nuclei in the posterior end of the embryo get 
separated from the rest during 10 division cycle. These nuclei will give the pole cells 
which are going to migrate to the gonad and become germ cells (Gilbert, 2000a; Gil­
bert, 2000b; Hay et al., 1988; Jaglarz and Howard, 1994). The rest of nuclei in the pe­
riphery undergo 4 more division cycles and at the 14th cycle the plasma membrane 
folds around them and cells begin to form (Foe and Alberts, 1983; Gilbert, 2000a; Gil­
bert, 2000b).
The first 13 divisions of the embryo are sustained by maternal deposition of cell 
cycle machinery components (Thompson, 2010). Maternally provided mRNA is also
11
responsible for the early polarization of the embryo along the anterior-posterior axis.
t V »  •  •  •After the 13 division cycle and cellularisation, the zygotic genes start to be tran­
scribed and the cell cycle is regulated in particular patterns (Thompson, 2010). A key 
regulator for the switch from maternal transcription to zygotic is Smaug, an RNA- 
binding protein which is required for the degradation of the maternal transcripts 
(Benoit et al., 2009). Following mitosis 16, nervous system cells continue to divide 
while epidermal cells exit the cell cycle (Edgar and O'Farrell, 1990). During late em­
bryogenesis, the larval tissues enter endoreplication cycles, while a few cells that have 
been determined to give rise to the adult structures continue to proliferate throughout 
larval development.
At the end of embryogenesis, larvae hatch and start feeding to promote their growth 
further. The larvae increase dramatically their size from the time they hatch until pupa­
tion. This growth is achieved through cell growth but not cell proliferation (Thompson, 
2010). Larval cells undergo endoreplication cycles which consist of DNA replication 
that is not followed by mitosis and thus, these cells become polyploid (Edgar and Orr- 
Weaver, 2001). Endoreplication accelerates growth rate since increased gene expres­
sion, due to multiple gene copies, leads to increased metabolism and increased resis­
tance upon DNA damage (Lee et al., 2009). In contrast, the cells that are destined to 
form the adult structures continue to divide during larval development. These cells are 
the imaginal disc cells (described below).
Cell cycle progression
The cell cycle in eukaryotic cells is composed of 4 different phases: S phase (DNA 
synthesis), M phase (Mitosis), and two Gap phases G1 and G2. The cell cycle progres­
sion is regulated by Cyclin-Dependent Kinases (Cdks) (Fig 2). In yeast there is only
12
one Cdk that is controlled by several cell cycle specific Cyclins (Andrews and Meas- 
day, 1998). In mouse there are several Cdks that couple with different Cyclins. How­
ever, only Cdkl is essential for viability, while Cdks2,4 and 6 are required in specific 
cell types (Santamaria et al., 2007). In Drosophila two Cdks are required for cell cycle 
progression: Cdkl for the G2/M transition and Cdk2 for Gl/S transition (Lane et al., 
2000; Stem et al., 1993).
Cdk activity is controlled by specific Cyclins that are synthesized periodically. In 
mammalian cells Cyclin D is required for Gl/S transition, Cyclin E for the initiation of 
S phase, Cyclin A for the exit from the S phase and Cyclins A and B for the entry to 
Mitosis (Budirahardja and Gonczy, 2009). In Drosophila Cyclin D is not essential 
(Meyer et al., 2000), but Cyclin E partners with Cdk2 and is required for the S phase 
(Sauer et al., 1995). Also, in Drosophila Cyclin A has not a role in S phase like in 
mammals, but it partners with Cdkl and alongside with Cyclin B-Cdkl regulate the 
onset of Mitosis (Knoblich and Lehner, 1993).
Cell cycle phases and the Cdk-Cyclin complexes that control the progression through them. 
There are four phases: DNA Syntesis (S), Mitosis (M), Gapl (G l) and Gap2 (G2). Cdk-Cyclin 
D functions to promote the G l/S  transition, Cdk-Cyclin E is required for the initiation o f S 
phase, Cdk-Cyclin A for the completion o f S phase (in mammal but not in Drosophila) and 
Cdk-Cyclin B together with Cdk-Cyclin A promote the entry to Mitosis. GO is a state that cells 
enter when they stop diving eg. upon unfavorable environmental conditions or upon differentia­
tion. (Budirahardja and Gonczy, 2009)
Cd k-Cycli n A
Figure 2
Cells that are in Gl enter S phase depending on availability of growth factors and
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nutrients. Progress through Gl/S is facilitated by Cyclin E upregulation (Lee and 
Yang, 2003). In mammals, extrinsic signals activate Cyclin D-Cdk which phosphory- 
lates retinoblastoma protein Rb (Kato et al., 1993). Thus, the E2F transcription factor 
is released by the Rb inhibition and leads to transcription of Cyclin E and other pro­
teins required for S phase (Ohtani et al., 1995). The Cyclin E-Cdk complex is addi­
tionally activated by inducing a feedback loop, as it phosphorylates further the Rb 
protein (Harbour et al., 1999; Hinds et al., 1992). In Drosophila, Cyclin D regulates 
growth but does not promote the Gl/S transition, and developmental signals activate 
directly Cyclin E (Meyer et al., 2000). Exit from S phase is facilitated by the inactiva­
tion of the Cdk-Cyclin E complex after degradation of Cyclin E. SCF (Skpl/Cullin/ F- 
box protein) ubiquitin ligase is responsible for the targeting and subsequent proteolysis 
of Cyclin E (Koepp et al., 2001).
Cells enter mitosis after the activation of Cdk-Cyclin A and Cdk-Cyclin B com­
plexes (Budirahardja and Gonczy, 2009). The abundance of Cyclin A and B is not the 
only requirement for Cdk activation. Weel kinase phosphorylates Cdk and keeps it in­
active until the Cdc25 phosphatase (String in Drosophila) removes the inhibitory 
phosphate group (Edgar and O'Farrell, 1989; O'Farrell, 2001; Russell and Nurse, 1987; 
Stumpff et al., 2004). Degradation of mitotic Cyclins is required for completion and 
exit from mitosis. In Drosophila embryos degradation of Cyclin A takes place before 
the metaphase to anaphase transition, Cyclin B get degraded during the metaphase/ 
anaphase transition and Cyclin B3 degradation occurs during anaphase (Sigrist et al., 
1995). Expression of stable forms of Cyclin A, Cyclin B and Cyclin B3 results in cell 
cycle arrest at metaphase, early anaphase and late anaphase respectively (Sigrist et al., 
1995). Anaphase promoting complex (APC) is required for the ubiquitination and sub­
sequent degradation of the mitotic Cyclins (Imiger, 2002). APC targets also securins 
and leads to their degradation, alleviating the inhibition of Separase which cleaves co­
14
hesion and allows the sister-chromatid disjunction (Peters, 2002).
Cell cycle progression is blocked if any of several processes are not finished cor­
rectly. Incomplete replication and DNA damage activate checkpoints during S phase 
or prior to mitosis entry, preventing cell cycle progression until the completion of rep­
lication or until the DNA damage is repaired (Dai and Grant, 2010). The delay in the 
progression of the cell cycle is achieved by the inactivation of Cdkl and it is facilitated 
by kinases ATM (Ataxia Telangiectasia Mutated) and Chkl (Checkpoint Kinase), 
which are known as Mei-41 and Grapes respectively in Drosophila (Fogarty et al., 
1997; Hari et al., 1995). These kinases act on regulators of Cdkl, such as Cdc25 
(String), whose function is blocked so that Cdkl will be kept inactive by Weel 
(Fumari et al., 1997; Raleigh and O'Connell, 2000). Another checkpoint delays the exit 
from mitosis by inhibiting APC activity upon misassembled spindle. The spindle as­
sembly checkpoint safeguards that spindle microtubules are attached correctly to the 
kinetochores before the initiation of anaphase (Zhou et al., 2002).
Cell cycle modulation in different developmental stages of Drosophila
In the beginning of embryogenesis, the 13 first division cycles are rapid and are 
sustained by the maternal deposition of cell cycle components. Therefore there are no 
Gap phases and the cell cycle is consisted by alternative S-M phases. After the cellu- 
larization at cycle 14, a G2 phase is added in order to allow the beginning of zygotic
•  •  thtranscription (Edgar, 1995). Following the 16 division cycle, the differentiating larval 
tissues enter endocycles with alternative S-G phases. In endocycling cells, Cdk2- 
Cyclin E activity oscillates, while the regulators of mitosis are downregulated so that 
mitosis will be prevented (Lilly and Duronio, 2005). In contrast, nervous system cells
• tVicontinue to divide through S-G2-M cycles even after 16 division cycle.
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During larval development, endoreplication is utilized by larval cells in many tis­
sues including gut, fat body, trachea, salivary glands, and the malpighian tubules. The 
nervous system cells divide during larval stages using G1-S-G2-M cycles. The same 
division cycles are followed by the imaginal disc cells, which at pupal stage will dif­
ferentiate to give rise to adult tissues. Abdominal histoblasts are also going to contrib­
ute in adult tissue formation, but remain arrested in G2 until the larval-pupal transition 
(Ninov et al., 2009).
Imaginal discs-growth and patterning
Imaginal discs are epithelial structures, which will form the adult appendages during 
pupation. The discs are formed initially from small groups of cells during embryo­
genesis. Late in embryogenesis they invaginate to form sac-like structures of 
monolayer columnar epithelium that are attached to the future larval epidermis. During 
larval stages the imaginal discs cells proliferate continuously, and by the end of larval 
development imaginal discs consist of tens of thousands of cells (Gilbert, 2000a). At 
metamorphosis, the imaginal discs evert out of the body and they differentiate to give 
rise to the adult structures (Held, 2002). There are nine pairs of imaginal discs that 
form the mouth parts, eyes and antennae, legs, wings and halteres (Fig 3). The head 
and thorax are formed by the imaginal discs, while the abdominal segments are formed 
by the abdominal histoblasts. Genitalia are formed from a pair of genital discs (Held, 
2002).
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Figure 3
Imaginal discs in Drosophila that give rise to the adult tissues during metamorphosis. There are 
nine pairs o f discs in the interior larval body: dorsal prothorax discs, eye antenna discs, three pairs 
of leg discs, wing discs, halter discs, two pair o f disc that form the mouthparts. Gelinalia are 
formed by the genital discs.
(Alberts B, Johnson A, Lewis J, et al. 2002. Molecular Biology o f the Cell. 4th edition.New York: 
Garland Science)
Cell division and growth in imaginal discs is controlled by developmental signaling 
pathways, so that cell proliferation will be coordinated in order to form an appendage 
of a particular shape and size. Imaginal disc cells receive positional information in 
which the respond by adjusting their division rate (Thompson, 2010). In the wing 
imaginal discs, for example, positional information is obtained through morphogens 
such as Dpp (Decapentaplegic), and Wg (Wingless). Dpp belongs to the TGF(3 family 
and it is expressed in the anterior-posterior boundary of the wing disc (Posakony et al., 
1990). Activation of Dpp signaling pathway induces the expression of omb and sal 
genes (Nellen et al., 1996). The gene sal is expressed by the cells that are close to the 
AP boundary and therefore receive a high concentration of Dpp, while omb is ex­
pressed in a wider domain than sal. Wingless belongs to the Wnt family and it is ex­
pressed in the dorso-vental boundary of the wing imaginal disc (Diaz-Benjumea and 
Cohen, 1995). Similar to Dpp, depending on the proximity of cells to the DV boundary 
and thus the concentration of Wg they receive, the expression of different genes is in­
17
duced (Zecca et al., 1996). Higher to lower concentration of Wg induces the expres­
sion of ac (achaete), Dll (Distal-less) and vg (vestigial) (Diaz-Benjumea et al., 1994; 
Neumann and Cohen, 1996; Phillips and Whittle, 1993). Following this general logic, 
each cell within an imaginal disc is specified according to the AP and DV axes. This 
results in different combinations of gene expression which specify the appropriate po­
sitional identity for each cell. Importantly, the mechanisms through which the posi­
tional signals integrate with the control of cell growth and cell division remain poorly 
understood.
Pupa formation-Ecdysone
The transformation of a larva to adult is completed during pupation. At pupal stage 
the larval tissues are destroyed while the adult tissue progenitor cells divide and differ­
entiate in order to form the adult structures. The process of pupa formation as well as 
the transition from one larval stage to the next is controlled by hormones. Ecdysone is 
the main hormone that regulates these transitions (Truman and Riddiford, 2002).
The prothoracicotropic hormone PTTH is a neuropeptide that is produced in the 
Drosophila brain and it stimulates the production of Ecdysone in the prothoracic 
glands (Nijhout, 1994). Ecdysone is a steroid hormone that is synthesized from choles­
terol. The prothoracic gland produces a precursor of Ecdysone that is released in 
hemolymph and it is converted into its active form 20E in midgut, fat body and mal- 
pighian tubules (Rewitz et al., 2006). When Ecdysone is bound to its receptor, it acti­
vates genes that encode transcription factors which in turn activate genes that prepare 
the tissues for stage specific biological processes (Crossgrove et al., 1996; Segraves 
and Hogness, 1990; Thummel et al., 1990).
Ecdysone levels increase before each larval molt, during which the old cuticle is
18
shed and a new cuticle is formed. A higher peak of Ecdysone promotes pupa formation 
at the end of the 3 rd instar larval stage and increased levels of Ecdysone during meta­
morphosis induce tissue differentiation (Gilbert, 2000a; Kozlova and Thummel, 2000; 
Nijhout, 1994). After the adult formation, Ecdysone levels decline.
Another important hormone that regulates the effects of Ecdysone is the Juvenile 
hormone JH. The JH is present during larval development and prevents metamorphosis 
during molting. At the larva to pupa transition the JH declines and Ecdysone in the ab­
sence of JH induces pupation (Riddiford, 1996).
Imaginal disc growth defects observed in mutation of a SUMOylation pathway 
enzyme
In the current study, defects caused by the disruption of the SUMOylation pathway 
are examined during development of Drosophila imaginal discs. The initial observa­
tion was that imaginal disc growth was abolished by a mutation in aosl, an enzyme re­
sponsible for the first step in the biochemical pathway of SUMO conjugation. 
Previously, no other reports have examined the general function of SUMOylation dur­
ing imaginal disc development. An overview of the SUMO pathway and its functions 
is provided below.
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Chapter 2 
SUMOylation
SUMO (Small Ubiquitin-related Modifier)
SUMO belongs to the Ubiquitin-like family of proteins that includes Nedd-8 and 
ISG15 (Schwartz and Hochstrasser, 2003). These proteins, like Ubiquitin, can be con­
jugated to other proteins and alter their properties like other post-translational modifi­
cations.
The SUMO gene was discovered initially in Saccharomyces cerevisiae (smt3). It 
was identified as a suppressor of a temperature sensitive allele of the centromeric pro­
tein Mif2 in a genetic screen (Melchior, 2000). It was in mammals, however, that 
SUMO protein was found to be covalently attached to another protein. The first pro­
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tein that SUMO was found to be conjugated to was the GTPase-activating protein, 
RanGAPl (Mahajan et al., 1997; Matunis et al., 1996). All eukaryotic organisms ex­
press SUMO. There are SUMO genes in protozoa, plants, fungi and metazoa but they 
are absent in bacteria and archaea (Meulmeester and Melchior, 2008). Yeast, insects 
and worms have a single SUMO gene, while higher eukaryotes have several. Plants 
express up to eight versions of SUMO (Hay, 2005). Mammals have at least 3 SUMO 
genes: SUMOl, SUM02 and SUM03 (Melchior, 2000). In the human genome there is 
a fourth SUMO gene, but is it unclear if SUM04 protein can be conjugated to other 
proteins. SUMOl, 2 and 3 are expressed ubiquitously in all tissues and developmental 
stages, while SUM04 seems to be expressed only in kidney and spleen (Johnson, 
2004; Meulmeester and Melchior, 2008).
SUMO proteins are only 18% identical with Ubiquitin in their primary sequence, 
but their folded structure resembles that of Ubiquitin. The charge distribution in their 
surface however is very different from Ubiquitin (Bayer et al., 1998). SUMO proteins 
are about 1 lkD in molecular weight but they appear at a higher size in SDS-PAGE. 
When they are attached to a substrate they add about 20kD in the molecular weight of 
the protein (Johnson, 2004). SUMOs are approximately 20 amino acids longer than 
Ubiquitin. SUMO in Drosophila is 90 amino acids. These extra residues are found in 
the unstructured N-terminal domain of the SUMO protein (Bayer et al., 1998).
SUMO conjugation pathway
The process of SUMO addition to substrates is called SUMOylation. All SUMO 
proteins are encoded in the genes as precursor molecules that have an extra C-terminal 
peptide which is removed by cleavage. This maturation step is necessary so that the C- 
terminal Glycine-Glycine motif can be exposed and used for the conjugation. The di-
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Glycine motif is found in most Ubiquitin-like proteins (Geiss-Friedlander and Mel­
chior, 2007). The processing of SUMO is carried out by specific proteases which are 
able also to remove SUMO from substrates.
The biochemical pathway of SUMO conjugation resembles that of Ubiquitin and it is 
evolutionally conserved (Fig 4). The SUMO conjugation process starts with the activa­
tion of SUMO by the El SUMO activating complex which is an Aosl/Uba2 het­
erodimer (Johnson et al., 1997). SUMO is activated by the formation of a thioester 
bond between the catalytic Cystein of the Uba2 subunit and the C-terminal Glycine of 
SUMO. ATP hydrolysis is required for this step. Secondly, the activated SUMO is 
transferred to the catalytic Cystein of the E2 SUMO conjugating enzyme, Ubc9. Fi­
nally the SUMO is transferred to the e-amino group of a Lysine side chain of the target 
protein with the assistance of E3 SUMO protein ligases. Between the Lysine of the 
substrate and the SUMO Glycine an isopeptide bond is formed (Bossis and Melchior, 
2006).
Many target proteins of SUMOylation contain a specific SUMO consensus motif 
\|/KxE. v|/ is a large hydrophobic amino acid mainly Isoleucin, Leucin or Valine, K is 
the Lysine residue where the SUMO gets attached, x is any residue and E is the Glu­
tamic acid (Rodriguez et al., 2001). Ubc9 recognizes and binds directly this motif. 
However, not all protein substrates have this motif and many proteins are modified at 
sites other than \|/KxE.
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Figure 4
SUMO conjugation pathway. Initially SUMO precursor molecules are processed by SENP prote­
ases so that the di-Glycine m otif in their C-terminal will be exposed. The mature SUMOs are acti­
vated by the Aos 1/Uba2 heterodimeric E 1 SUMO activating complex. A thioester bond is formed 
between the C-terminal Glycine o f SUMO and the catalytic Cystein o f Uba2. The reaction re­
quires ATP hydrolysis. Subsequently, SUMO is transferred to the Ubc9 E2 SUMO conjugation 
enzyme. Finally Ubc9 transfers SUMO to a Lysine residue of target proteins assisted by E3 
SUMO ligases. SENPs recognize and de-conjugate SUMO from substrates, so SUMO is released 
and becomes available for a new conjugation cycle (Geiss-Friedlander and Melchior, 2007).
SUMOylation is a reversible protein modification and there are proteases that re­
move SUMO from substrates (Mukhopadhyay and Dasso, 2007). Deconjugation re­
leases the SUMO protein which is available to start another conjugation cycle. SUMO 
attachment to proteins is very unstable and cleaving enzymes deSUMOylate rapidly all 
conjugates upon cell lysis. Therefore, with most experimental treatments, the SUMO 
conjugation is lost. It is required to use denaturing conditions or inhibitors of the 
cleaving enzymes in order to recover SUMO conjugated protein (Meulmeester and 
Melchior, 2008). In addition, only a small percentage of the substrate is SUMOylated 
at a steady state. This percentage can be even less than 1% in many cases (Johnson,
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2004). These facts caused a delay in the discovery of SUMO conjugation which was 
only found in ’96-’97 in the RanGAPl protein, where SUMO modification is unusu­
ally stable (Mahajan et al., 1997; Matunis et al., 1996).
SUMOylation is essential in most organisms: budding yeast, nematodes, fruit flies, 
mice, and plants (Arabidospis thaliana). In multicellular organisms SUMOylation is 
thought to take place in all tissues and developmental stages (Geiss-Friedlander and 
Melchior, 2007). It affects many biological processes and it is required for cell viabil­
ity (Hay, 2005). The only exception known today is fission yeast. In fission yeast 
(S.pombe), upon disruption of the single SUMO gene, the cells are sick but viable 
(Tanaka et al., 1999).
SUMOl and SUM02/3 isoforms and SUMO chains
SUMO proteins in metazoans can be categorized into two subfamilies: SUMOl and 
SUM02/3. The mammalian SUM02 and SUM03 proteins are about 95% identical in 
their primary amino acid sequence with each other, while they are only 50% identical 
with SUMOl (Johnson, 2004). Xenopus laevis and zebrafish have both SUMOl and 
SUM02/3 (Melchior, 2000). C.elegans has a single SUMO gene that encodes a 
SUMO protein that falls into SUMOl family (Choudhury and Li, 1997). Drosophila 
melanogaster has a single SUMO that falls into SUM02/3 category (Huang et al., 
1998) and mammals have all SUMOl, SUM02 and SUM03 proteins. The SUMOs in 
fungi and plants form distinct groups from the SUMOl and SUM02/3 categories 
(Melchior, 2000).
All SUMO isoforms are conjugated by the same El and E2 enzymes. SUMOl seems 
to have distinct function from SUM02/3, while SUM02 and SUM03 are assumed to 
have no functional differences. It is not known yet whether each individual SUMO is
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essential in organism viability. It seems that SUMOl deficiency cannot be compen­
sated by SUM02/3 in mice as it is reported that SUMOl disruption results in embry­
onic lethality (Alkuraya et al., 2006). However, this result was not reproduced in later 
study (Zhang et al., 2008).
In mammals, it has been shown that different substrate proteins are preferentially 
modified with different SUMO isoforms. An example is the RanGAPl which is 
mainly modified by SUMOl but is not strongly modified by SUM02/3 (Johnson, 
2004), while Topoisomerase II is predominantly modified by SUM02/3 (Gill, 2004). 
Some target proteins are modified equally by SUMOl and SUM02/3. The conjugation 
of the different SUMO isoforms to the substrates is probably regulated by the E3 li­
gases, although the selection mechanism is not known yet. SUMOl and SUM02/3 are 
also differentially affected by the SUMO proteases (Meulmeester and Melchior, 2008).
Another difference between SUMO 1 and SUM02/3 is that at any given time the vast 
majority of SUMOl in the cell is conjugated to other proteins whereas there is a large 
pool of free SUM02/3 (Johnson, 2004). The conjugation of SUM02/3 is highly in­
creased in response to various stresses. This could reflect a different regulation of 
SUM02/3 conjugation or just the consequence of having a large reservoir of free 
SUM02/3 available in the cell while free SUMOl is limited (Bossis and Melchior, 
2006). Therefore, one function of SUM02/3 may be to provide a large pool of free 
SUMO for response to stress.
In addition, there is a difference in the capacity for chain formation between 
SUMOl and SUM02/3. SUM02 and SUM03 have a SUMO consensus motif \|/KxE 
in their unstructured N-terminal region. This consensus can serve as an attachment site 
for SUMOylation, thus allowing SUM02/3 to form poly-SUMO chains (Ulrich, 
2008). The target Lysine of the consensus motif in SUM02/3 is K11. Yeast SUMO 
(Smt3) has three such motifs around K11, K15 and K19 and it can also form chains.
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This SUMO acceptor site is absent from SUMOl. In vitro, SUMOl can form chains 
through non-consensus Lysines, but less efficiently (Ulrich, 2008). SUMOl has been 
found conjugated to SUM02 or SUM03 in cells, serving probably as a terminator of 
poly-SUMO chains.
In vivo most Lysine residues that are modified have a single SUMO molecule at­
tached to them and often proteins are multiply modified by attachment of mono- 
SUMO at different sites. To date, poly-SUMO chains have been observed in cells only 
on a few proteins: the Histone deacetylase HDAC4 in mammalian cells, the transcrip­
tional regulator HIF-la and the PCNA in yeast which was found to carry an oli­
gomeric Smt3 chain (Matic et al., 2008; Tatham et al., 2001; Windecker and Ulrich, 
2008).
The function of SUMO chains is not clear. In yeast, chain formation is not essential 
for viability and inhibition of Smt3 polymerization through mutation of the acceptor 
Lysines has no effect on vegetative growth. However, SUMO chain formation is re­
quired for efficient sporulation, which suggests a role of poly-SUMO chains in meiotic 
cell division (Ulrich, 2008).
The E l SUMO activating enzyme (Aosl/Uba2)
The El SUMO activating enzyme catalyzes the first step of SUMO conjugation. It is 
a heterodimer consisted of Aosl and Uba2 proteins and both subunits are conserved 
from yeast to human. In most organisms there is only one El SUMO activating en­
zyme that is required for the conjugation of all SUMO isoforms on substrates. Only 
Arabidopsis has been found to contain two Aosl (SAE1) genes. Each of these proteins 
forms a pair with the single Uba2 (SAE2) protein (Johnson, 2004).
The Aosl/Uba2 enzyme resembles the El ubiquitin activating enzyme, although the
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latter is monomeric. In S. cerevisiae Aosl is 29% identical with the N-terminal region 
of Ubiquitin El (Ubal), while Uba2 is 28% identical to the C-terminal region of Ubal 
(Melchior, 2000). The human El SUMO activating enzyme crystallization revealed 
that the Aosl and Uba2 dimerization occurs through the two conserved adenylation 
domains, one in each subunit (Fig 5). The adenylation domain protein sequence in 
Uba2 surrounds the protein sequence of the catalytic Cystein domain. Another domain 
in the Uba2, the Ubl domain that is found in the C-terminal of all El enzymes, is re­
sponsible for recruiting the E2 enzyme for the transfer of SUMO to E2 (Lois and 
Lima, 2005).
AUbL ACteraui-549) ANLS(i-6<»)
158 Cys 173 Cys domain 386 441 UbL 549| 1*40
^ -------------------------Zn — NLS
SUMO I h h i  
Figure 5
The domains of human A osl/Sael and Uba2/Sael E l subunits. Uba2 contains the catalytic Cys­
tein (yellow) that forms thioester bond with SUMO. The Uba2 adenylation domain surrounds the 
sequence o f the catalytic Cys domain (pink) and it interacts with the Aosl which also contains an 
adenylation domain. The UbL domain in Uba2 (red) is required for recruitment o f the E2 enzyme 
so that SUMO can be transferred to E2. (Lois and Lima, 2005)
Despite the heterodimeric form of the SUMO El activating enzyme, the Aosl and 
Uba2 subunits do not seem to be regulated or function separately. Uba2 alone is not 
sufficient for the formation of thioester bond and a second protein is required (Johnson 
et al., 1997). In the same study it was shown that in vitro Aosl and Uba2 can form an 
active El SUMO activating enzyme. In addition all cellular Uba2 and Aosl are found 
as heterodimers (Johnson, 2004). Aosl and Uba2 are likely to be expressed ubiqui­
tously in mammals, since cDNAs for both have been found in many different embry­
onic and adult tissues and also in culture cells. In S.cerevisiae both aosl and uba2
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genes are essential for viability (Melchior, 2000). In Drosophila, nothing is known 
about the biological requirements for aosl and uba2 specifically, or the SUMO El ac­
tivity generally.
The E2 SUMO conjugation enzyme (Ubc9)
After activation of SUMO by the El activating enzyme, SUMO is transferred to the 
E2 conjugation enzyme. A thioester is formed between SUMO and Ubc9, which 
serves as intermediate for the transfer of SUMO to the substrate. Ubc9 is the only E2 
SUMO conjugation enzyme in all organisms while there are more than 20 E2 enzymes 
for Ubiquitination (Geiss-Friedlander and Melchior, 2007; Gill, 2004). Ubc9 is con­
served from yeast to human. Like the genes that encode for SUMO, Aosl, and Uba2, 
the Ubc9 gene is essential in yeast and in all organisms tested thus far, except in 
S.pombe (Johnson, 2004).
The SUMO consensus motif \j/KxE in substrate proteins is recognized and bound di­
rectly by Ubc9 (Bernier-Villamor et al., 2002). This is the reason that Ubc9 and 
Aosl/Uba2 enzymes are sufficient for SUMOylation of substrates in vitro. However, 
except RanGAPl, the in vitro SUMOyation of other substrates with the presence of 
only Ubc9 and Aosl AJba2 is not very efficient, suggesting that E3 ligases are required 
to accelerate the process of SUMO transfer to substrate (Hay, 2005). In vivo, E3 li­
gases are probably regulating substrate selection, especially for substrate proteins that 
lack the SUMO consensus motif.
E3 SUMO Ligases
The E3 SUMO ligases facilitate the transfer of SUMO from the E2 conjugation en­
zyme to the target Lysine residue of the substrate. The main category of SUMO E3 li-
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gases that have been found so far consist of proteins that are characterized by the pres­
ence of SP-RING motif. This motif is similar to the RING finger in E3 Ubiquitin li­
gases and it is essential for the E3 SUMO ligase function (Kahyo et al., 2001; 
Takahashi et al., 2001). The SP-RING E3 SUMO ligases function as adaptor proteins 
for Ubc9-SUMO thioester and substrate, so they facilitate SUMO transfer by enhanc­
ing interaction between E2 enzyme and target proteins, or by positioning them in a fa­
vorable orientation for the transfer (Geiss-Friedlander and Melchior, 2007).
The SP-RING E3 SUMO ligases include the PIAS family members (Protein Inhibi­
tor of Activated ST AT transcription factors). The PIAS family has two members in
S. cerevisiae (Sizl and Siz2) which are required for most SUMO conjugation in yeast, 
as shown in sizl, siz2 double mutants (Johnson and Gupta, 2001). Sizl is required for 
SUMOylation of PCNA and septins (Johnson and Gupta, 2001; Stelter and Ulrich, 
2003). Five members of PIAS family have been found in mammals: PIAS1, PIASy, 
PIAS3, PIASxa and PIASxP (Geiss-Friedlander and Melchior, 2007). PIAS1 and 
PIAS3 proteins are expressed in all cell types, while PIASx and PIASy seem to be ex­
pressed mainly in testis. PIAS proteins are found in the nucleoplasm and in PML nu­
clear bodies (Johnson, 2004).
Other SP-RING E3 SUMO ligases are the MMS21 in yeast (NSE2), which is a sub­
unit of the multiprotein complex SMC5-SMC6 that is required for vegetative growth 
and for DNA repair (Andrews et al., 2005; Potts and Yu, 2005; Zhao and Blobel,
2005), and the yeast protein Zip3 which is meiosis specific (Cheng et al., 2006).
Another type of E3 SUMO ligase is the nuclear pore protein RanBP2 in vertebrates. 
It is located at the cytoplasmic fibrils of the nuclear pore complex. It has a catalytic 
domain that interacts with Ubc9 and SUMO but not with substrates, which suggests 
that RanBP2 does not act as an adaptor between E2 and target proteins like the SP 
RING E3 ligases. It is likely that RanBP2 accelerates the reaction by positioning
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Ubc9-SUM0 thioester in such a way that the capacity of SUMO transfer to substrate is 
increased (Reverter and Lima, 2005). In vivo there are no known targets of RanBP2, 
but in vitro it enhances the SUMOylation of Histone deacetylase HDAC4, Spl 00 and 
PML (Geiss-Friedlander and Melchior, 2007; Kirsh et al., 2002; Pichler et al., 2002; 
Tatham et al., 2005).
E3 SUMO ligase activity has also been found in the Pc2 protein of the polycomb 
group. Polycomb group protein complexes have a Histone methylation activity and 
they participate in gene silencing. Pc2 recruits in Polycomb group complex the CtBP 
transcriptional corepressor and it enhances its SUMOylation in vivo and in vitro 
(Kagey et al., 2005; Kagey et al., 2003). It is not very clear how Pc2 facilitates the 
SUMO transfer, but it is likely that the C-terminal of the protein recruits Ubc9 and 
CtBP in Polycomb group subnuclear domains and the N-terminal positions the Ubc9 
for efficient transfer of SUMO to CtBP (Hay, 2005). HDAC4 has been suggested to 
have an E3 SUMO ligase activity as well. HDAC4 is a SUMOylation target but it also 
enhances SUMOylation of other proteins (MEF-2, LXRp, HIC1). In addition HDAC4 
binds Ubc9 and the deacetylase activity of HDAC4 is not always required for the en­
hancement of SUMOylation of other proteins, therefore it is possible that HDAC4 
functions as E3 ligase too (Geiss-Friedlander and Melchior, 2007).
SUMO Deconjugation Enzymes (Ulp/SENPs)
The processing of newly synthesized SUMO to its mature form and the removal of 
conjugated SUMO from substrates is carried out by specific SUMO proteases. These 
proteins were initially identified in yeast (Ulp proteins). In S. cerevisiae there are 2 
such proteases Ulpl and Ulp2 (Li and Hochstrasser, 1999; Li and Hochstrasser, 2000). 
Based on sequence similarity with U lpl, 8 protein homologues were found in humans
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(SENPs 1-8). Later studies revealed that only 6  of them are true SUMO specific prote­
ases, as SENP3 and SENP4 were discovered to be the same protein and SENP8 is a 
Nedd-8  specific protease and not a SUMO protease (Mukhopadhyay and Dasso,
2007).
SUMO proteases are characterized by a catalytic isopeptidase domain of about 200 
amino acids that contains the catalytic Cystein-Histidine-Asparagine triad (Cystein 
proteases). This catalytic domain is typically located in the C-terminal region of the 
proteases, while the N-terminal region is important for the intracellular localization of 
each protease (Melchior et al., 2003). In addition to their isopeptidase catalytic do­
main, some of the SUMO proteases have also a hydrolase catalytic domain in the C- 
terminus which is required for the maturation of SUMO precursors (Melchior et al., 
2003). The SUMO proteases can be divided in two evolutionary subgroups: one that 
contains Ulpl, SENP1, SENP2, SENP3 and SENP5 and the other that contains Ulp2, 
SENP6 and SENP7 (Mukhopadhyay and Dasso, 2007).
In yeast, Ulpl is essential for viability. Overexpression of mature SUMO in the ulpl 
mutant cells rescues weakly the phenotype, which shows that Ulpl is required for 
processing of SUMO but its function in SUMO deconjugation is also important (Li 
and Hochstrasser, 1999). Ulp2 is not essential for vegetative growth but it is required 
for meiotic division, chromosome segregation and temperature sensitive growth (Li 
and Hochstrasser, 2000; Strunnikov et al., 2001). Ulp2 seems to have only a minor role 
in SUMO processing but it has a role in SUMO deconjugation and especially in decon­
jugation of SUMO chains. Deletion of Ulp2 results in accumulation of high molecular 
weight conjugates, which are eliminated in the presence of SUMO that has mutated 
acceptor sites for chain formation (Bylebyl et al., 2003). Ulpl is localized in the nu­
clear pores, while Ulp2 is found in the nucleoplasm.
Like Ulpl, the proteases SENP1 and SENP2 are active in SUMO processing.
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SENP1 catalyzes more efficiently SUMOl processing and less efficiently SUM02 
processing, while SENP2 is more efficient in the catalysis of SUM02 maturation than 
in SUMOl (Reverter and Lima, 2004; Shen et al., 2006; Xu and Au, 2005). SUM03 
can be processed efficiently by SENP5, but SUMOl cannot (Di Bacco et al., 2006; 
Gong and Yeh, 2006). This substrate preference seems to be attributed to the different 
C-terminal extension sequence of the immature SUMO isoforms beyond the diGly 
motif (Mukhopadhyay and Dasso, 2007).
The mature forms of SUM02/3 are almost identical so proteases cannot distinguish 
them in deconjugation, while SUMOl is discriminated during deconjugation. Prefer­
ential deconjugation by SENPs can occur also between different substrates. For exam­
ple SENP1 can distinguish SUMOl-RanGAPl from SUMOl-SplOO (Shen et al., 
2006). Probably this is due to different structures of target proteins that cannot be 
bound by certain proteases. Similar to Ulpl, SENP1 and SENP2 are associated to the 
nuclear pores. SENP3 and SENP5 are localized in the nucleoli. SENP6  and SENP7 are 
localized in the nucleoplasm and SENP6  is not involved in SUMO processing, and but 
it can deconjugate SUM02/3 chains like Ulp2 (Mukhopadhyay and Dasso, 2007).
SUMOylation and downstream effectors (SIM proteins)
SUMOylation changes the molecular surface of the substrate proteins. Therefore its 
presence on a target protein can either inhibit protein-protein interaction by masking a 
binding site or create a new protein-protein interaction. In the second case, it has been 
found that some proteins contain SUMO Interacting Motifs (Liu et al.), domains that 
allows proteins to bind SUMO non-covalently and thus to interact with SUMOylated 
proteins. The SIM motif consists of a short hydrophobic sequence flanked by acidic 
amino acid residues (Geiss-Friedlander and Melchior, 2007). The hydrophobic part
usually contains a sequence of four amino acids V/I/L - X - V/I/L - V/I/L (Geoffroy 
and Hay, 2009).
SIM domains have been found in the SUMOylation enzymes such as Uba2 and the 
PIAS E3 ligases, and it seems to contribute in their enzymatic function (Geiss- 
Friedlander and Melchior, 2007). The SIM motif has also been found in some E3 
ubiquitin ligases that recognize SUMOylated proteins and promote their polyubiquiti- 
nation and subsequent degradation by the proteasome. Such proteins are the Slx5-Slx8 
heterodimer in S. cerevisiae and the Rfpl -Slx8 and Rfy2-Slx8 heterodimers in S.pombe. 
The Slx8 subunit appears to be responsible for the RING-dependent ubiquitin ligase 
activity while the other subunit recognizes SUMO via the SIM domains that it carries 
(Ulrich, 2008). In mammals, RNF4 is the homolog of these yeast proteins. RNF4 is a 
RING finger E3 ubiquitin ligase that has in its N-terminal region four potential SIM 
domains and it has a strong affinity of SUMO chains (Geoffroy and Hay, 2009).
Regulation of SUMOylation
Many proteins undergo SUMO conjugation and deconjugation cycles, depending on 
internal or external stimuli. Given the limited number of enzymes in the SUMO conju­
gation pathway, a critical question is how SUMOylation is regulated. Some mecha­
nisms that regulate SUMOylation at the substrate level or at the cell level are reported 
below.
Changes in the localization of the substrate protein or the E3 SUMO ligase /SUMO 
protease that recognize the substrate can influence the SUMOylation at the substrate 
level. An example is the change in the localization of Sizl (E3 ligase) in S.serevisiae. 
Sizl is nuclear during interphase, but during mitosis it translocates in the bud neck 
where it promotes SUMOylation of the cytoskeletal proteins Septins (Johnson and
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Gupta, 2001).
Also, it has been showed that Ubc9 from yeast and mammals is SUMOylated in vi­
tro and in vivo. SUMOylation of Ubc9 affects the substrate specificity and enhances 
(SplOO) or decreases (RanGAPl) SUMOylation of certain targets (Knipscheer et al.,
2008). The alteration of Ubc9 target specificity is due to the expansion of the Ubc9 
binding surface upon SUMOylation. The SUMO protein that is attached to Ubc9 is 
recognized by the SIM domain of the substrate, when the SIM is located at an appro­
priate site for the interaction with SUMO. This binding between the SIM domain of 
the substrate and the SUMOylated Ubc9 enhances the interaction between enzyme and 
target, resulting in more efficient SUMO transfer (Knipscheer et al., 2008).
Another way to achieve SUMOylation target specificity is the interaction with other 
post-translational modifications. Phosphorylation of some targets enhances their SU­
MOylation (Geiss-Friedlander and Melchior, 2007). A phosphorylation-dependent 
SUMOylation motif has also been found, which is the SUMO consensus motif fol­
lowed by a phosphorylated Serine and a Proline (\|/KxExxSpP). This motif has been 
found in various proteins (HSF1, SNIP1, MEF2). The phosphate group probably en­
hances the interaction between the substrate and the Ubc9. Phosphorylation can have a 
negative effect in SUMOylation of some targets as well (IicBa, p53, c-Jun, c-Fos) 
(Geiss-Friedlander and Melchior, 2007). It is not known yet how phosphorylation 
regulates negatively SUMOylation but it could be due to the masking of the SUMO 
acceptor site in these targets or due to a change in their subcellular localization.
Other post-translational modifications that interfere with SUMOylation are Ubiquiti- 
nation, Acetylation and Methylation, as they all modify Lysine residues and they can 
compete for the same Lysine in a substrate. For example Acetylation and SUMOyla­
tion modify the same Lysine residue in Sp3 (Sapetschnig et al., 2002), while Ubiquiti- 
nation and SUMOylation modify the same Lysine in IxBa and PCNA (Desterro et al.,
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1998; Hoege et al., 2002). Depending on the target, the different post translational 
modifications can prevent each other (IicBa) or they are regulated independently upon 
different signals in order to serve different functions of the target protein (PCNA).
Regulatory mechanisms that target the enzymes of the SUMOylation pathway can 
affect global SUMOylation. Various stresses like heat shock, osmotic stress and oxida­
tive stress cause a dramatic change of SUMO conjugation. Heat shock and osmotic 
stress increase global SUMOylation (Kurepa et al., 2003; Saitoh and Hinchey, 2000), 
while oxidative stress results in loss of global SUMOylation (Bossis and Melchior, 
2006). The decrease in SUMOylation is caused by the inhibition of SUMO conjuga­
tion enzymes by the induction of a disulfide bridge between the catalytic Cystein of 
Uba2 and the catalytic Cystein in Ubc9 (Bossis and Melchior, 2006). The mechanism 
of increase in global SUMOylation is not known yet.
Finally, it has been shown that viral proteins can cause alterations in global SU­
MOylation. Garni protein from the CELO adenovirus causes a dramatic decrease in 
SUMOylation when it is expressed in cells. The decrease in SUMOylation is caused 
by the elimination of the El SUMO activating enzyme and E2 SUMO conjugation en­
zyme. Garni interacts with Aosl subunit and it brings it in proximity with an E3 ubiq­
uitin ligase which results in ubiquitination of the El enzyme and subsequently its 
degradation (Chiocca, 2007). Garni induces the degradation of Ubc9 as well, but the 
mechanism is unknown.
Functions of SUMOylation
SUMOylation is required for several cellular processes, and protein targets of SU-
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MOylation are found to participate in many different biochemical pathways. Some 
functions of SUMOylation are described bellow.
Cell cycle
SUMOylation is involved in multiple stages of the cell cycle. In budding yeast, def- 
fects in SUMO conjugation by depletion of Ubc9 (Seufert et al., 1995) or in SUMO 
deconjugation by depletion of the Ulpl protease (Li and Hochstrasser, 1999) result in 
cell cycle arrest in G2/M. This demonstrates the importance of SUMOylation in cell 
cycle progression.
SUMOylation is also required for chromosome cohesion. Cohesion of the sister 
chromatids ensures that the chromosomes are paired and aligned properly and that 
their dissociation will occur at the right time of mitosis. Pds5 in S. cerevisiae associates 
with the cohesion protein complex and is required for the maintenance of chromosome 
cohesion (Watts, 2007). Pds5 is SUMOylated in vivo in a cell cycle dependent fashion. 
Its SUMOylation begins before S phase and it is maximal at anaphase (Stead et al., 
2003). Therefore, it seems that SUMOylation of Pds5 enables the release of cohesins 
in anaphase so chomosomes can segregate.
Another target of SUMOylation that is involved in chromosome cohesion is the 
Topoisomerase II. Topo II is SUMOylated both in yeast and in vertebrates and its 
SUMOylation during mitosis is required for the chromosome segregation (Azuma et 
al., 2003). Also the centromeric protein MIF2 (CENP-C in vertebrates), which is es­
sential for chromosome segregation, interacts genetically with SUMO and that led to 
the discovery of SUMO gene (Melchior, 2000).
In addition, SUMOylation is required for APC (Anaphase Promoting Complex) me­
diated proteolysis of mitotic Cyclins and securin Pdsl (Dieckhoff et al., 2004; Seufert 
et al., 1995). Degradation of mitotic Cyclins is required for mitotic exit, while degra­
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dation of Securin allows the activation of Separase. Separase in turn acts on cohesins 
and releases the two sister chromatid cohesion so that the chromosome segregation can 
take place.
Gene expression
SUMOylation can affect gene expression by regulating the assembly and activity of 
transcription factors or the recruitment of chromatin modifying enzymes. SUMO can 
also be a part of the Histone modification code as Histone H4 is shown to be SUMOy­
lated (Hay, 2005).
SUMOylation can have a positive or a negative influence in the transcription. SU­
MOylation of the heat shock transcription factors HSF1, HSF2 and the p53 protein in­
creases their transcriptional activity (Goodson et al., 2001; Gostissa et al., 1999; Hong 
et al., 2001). In most cases, however, SUMOylation of transcription factors results in 
repression of transcription. Mutation of the SUMO acceptor site in Elk-1, STAT-1, Sp- 
3 has been shown to increase the transcription from the responsible promoters 
(Johnson, 2004). For some transcription factors SUMOylation can negatively affect 
their synergistic binding in the multiple binding sites of promoters, like in case of an­
drogen receptor and the glycocorticoid receptor (Holmstrom et al., 2003). In other 
transcriptional factors like Smad4, SUMOylation can activate or repress transcriptional 
activity depending on the target promoter (Hay, 2005).
Trancriptional repression upon SUMOylation can be achieved by the recruitment of 
co-repressors that modify chromatin structure. For instance, upon SUMOylation, p300 
and Elk-1 recruit in the promoter Histone deacetylase HD AC enzymes that induce 
changes in chromatin and result in inhibition of transcription (Girdwood et al., 2003; 
Yang and Sharrocks, 2004).
A different mechanism by which SUMOylation can repress transcription is the re­
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cruitment of the SUMOylated transcription factors in the repressive environment of 
subnuclear domains, such as the PML nuclear bodies. The PML (promyelocytic leu­
kemia) gene was discovered in a chromosomal translocation that results in the fusion 
of PML protein with retinoic acid receptor and causes Acute Promyelocytic Leukemia 
(Salomoni and Pandolfi, 2002). Under normal conditions PML protein is found in nu­
clear bodies. PML is SUMOylated and it recruits many other proteins like SplOO, 
Daxx and p53 which can also get SUMOylated. SUMOylated Spl 00 can interact with 
Heterochromatin protein 1 (HP1) in vitro and therefore it is possible that the recruit­
ment of chromatin modifying enzymes in these nuclear bodies changes chromatin to a 
repressed state locally (Seeler et al., 2001).
DNA repair
SUMOylation has been found to play a role in DNA damage repair as well. The 
thymidine DNA glycosylase (TDG) is an enzyme that has an important function in the 
repair of mismatched bases in DNA. TDG removes the thymidine or uracil base from 
the mismatch with Guanidine and subsequently a downstream enzyme repairs the 
abasic site (Hardeland et al., 2001). Non-SUMOylated TDG in vitro completes one 
round of reaction and then it binds to the product. SUMOylation of TDG results in re­
duced affinity of the enzyme for DNA structure and therefore TDG is able to complete 
multiple rounds of reaction in vitro. Thus, it seems that SUMO modification of the 
TDG enzyme is required for the dissociation of TDG from DNA after the base re­
moval so that the next enzyme will be allowed to repair the gap (Hardeland et al., 
2002).
SUMOylation appears to regulate also Topoisomerase I which is a DNA repair en­
zyme that is implicated in the recognition of DNA lesions (Liu et al., 2000). Another 
enzyme that is controlled by SUMOylation is the PCNA (proliferating cell nuclear an-
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tigen). SUMOylation of PCNA during S phase inhibits the recombination repair of 
DNA. SUMO modification of PCNA probably ensures that DNA repair will not take 
place in the wrong phase of the cell cycle (Pfander et al., 2005).
Subcellular localization
SUMOylation has been shown to induce changes in the subcellular localization of 
target proteins. RanGAPl that was the first protein on which SUMO was found to be 
attached is involved in nuclear transport of proteins. RanGAP changes localization up­
on SUMOylation, as unmodified protein is cytoplasmic while SUMOylated RanGAPl 
protein translocates to nuclear pore complexes were it associates with RanBP2 
(Mahajan et al., 1997; Matunis et al., 1996). During mitosis SUMO modified Ran­
GAPl gets recruited in mitotic spindle (Joseph et al., 2002).
As it is described above, PML SUMOylation is required for the localization of other 
proteins in PML nuclear bodies (Hay, 2005). Another example of SUMO-dependent 
translocation is the case of NEMO, the kinase regulator of I k B ,  which is localized to 
the nucleus upon fusion to SUMO (Huang et al., 2003). Also, the CtBP transcriptional 
co-repressor has been shown to lose its nuclear localization when its single SUMO ac­
ceptor site is mutated (Lin et al., 2003).
Signal transduction
SUMO conjugation influences signal transduction. It can affect the activity of tran­
scription factors that are downstream of signaling pathways as mentioned above 
(Smad4, Elk-1 , STAT-1, androgen receptor, GR). SUMOylation can also regulate the 
nuclear translocation of a transcription factor, as in the case of NFkB where SUMOy­
lation prevents the degradation of its inhibitor IicBa which keeps NFkB in the cyto­
plasm (Desterro et al., 1998). SUMOylation can regulate signal transduction through
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regulation of the activation of the receptor, as it has been shown for type ITGF-P re­
ceptor (Kang et al., 2008).
SUMOylation and development
It is observed that disruption of SUMOylation in yeast leads to cell cycle progres­
sion defects. Depletion of Ubc9 causes a cell cycle arrest and the majority of cells ap­
pear to be large budded with increased cell volume and a single nucleus. These cells 
have their DNA replicated and they arrested at G2/M (Seufert et al., 1995). Similarly, 
tetrad analysis of Uba2 depleted cells showed that these cells produce microcolonies of 
50-100 enlarged cells (Dohmen et al., 1995). They report also that Auba2 microcolo­
nies consisted of 30% of cells with no bud, 60% of cells with one large bud and 10% 
of cells with two buds (Dohmen et al., 1995). Another study describes also an identical 
phenotype for Aosl depleted cells (Johnson et al., 1997). Upon tetrad analysis of 
A aosl cells, the authors observe that the mutant cells grow for a few generations and 
form colonies of about 100  cells, but the cells eventually become enlarged and finally 
lysed (Johnson et al., 1997).
Despite the detailed phenotypic analysis in yeast, there is not enough information 
about the role of the SUMOylation pathway in the development of multicellular organ­
isms. There are only a few studies that describe the developmental defects that are 
caused by the blockage of global SUMOylation.
In mice, an Ubc9 (SUMO E2) null allele causes early embryonic lethality 
(Nacerddine et al., 2005). The mutant embryos survive until the blastocyst stage and 
they undergo implantation in uterus, but they die afterwards. The authors suggest that 
the lethality could be attributed to the decline of maternal Ubc9 protein. Culture of the 
blastocysts in vitro showed that Inner Cell Mass (ICM) cells of Ubc9 mutant embryos
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die through apoptosis, while the non-dividing trophoblastic cells remain alive 
(Nacerddine et al., 2005). When examined closely, the ICM cells of the mutant em­
bryos had mitotic chromosome condensation and segregation defects.
In zebrafish, injection of a dominant negative form of Ubc9 protein into one-cell 
stage embryos leads to embryonic lethality and extensive cell death (Nowak and 
Hammerschmidt, 2006). Dominant negative Ubc9 protein produces a severe pheno­
type as it interferes with endogenous Ubc9 protein that is maternally supplied. In con­
trast, injection of antisense morpholino oligonucleotides against ubc9 mRNAs at one­
cell stage embryos causes defects later in development, such as eye and brain size re­
duction and craniofacial malformation (Nowak and Hammerschmidt, 2006). Ubc9- 
depleted cells exhibit lower proliferation rates and Fluorescence Activated Cell Sorting 
analysis (FACS) showed an increase in the percentage of cells with replicated DNA 
(4n), and a small fraction of cells with 8n DNA content (Nowak and Hammerschmidt,
2006). In this study they also demonstrate that cell differentiation is not affected in 
Ubc9 mutant fish.
SUMOylation in growth and patterning of Drosophila
In Drosophila, SUMOylation regulates signaling pathways that are related with pat­
tern formation, through the activity of the transcription factors that are downstream in 
the signaling cascade. Transcription factor Medea (Smad4 homologue) is found to be a 
SUMOylation target in vitro and in vivo (Miles et al., 2008). Medea is a downstream 
effector of Dpp signaling pathway and, together with phosphorylated Mad, it translo­
cates to the nucleus and it activates the transcription of target genes (Affolter et al., 
2001). SUMOylation of Medea regulates negatively the Dpp signaling pathway as it 
promotes nuclear export of Medea and thus, it appears to regulate the duration and the
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range of Dpp signaling (Miles et al., 2008). In addition, SUMOylation seems to en­
hance the transcriptional activity of Vestigial (vg) as shown by the genetic interaction 
between SUMO and Vg (Takanaka and Courey, 2005). Spalt (sal) and Spalt-related 
(salr) transcription factor are also found to be SUMO targets in vitro and it is shown 
that SUMOylation changes their subnuclear localization in vivo (Sanchez et al., 2010). 
Genetic interaction showed that SUMO enhances Spalt and Spalt-related activity in 
induction of vein formation in the wing (Sanchez et al., 2010). Further, SUMOylation 
has been found to regulate negatively Dorsal (NF-kB family) transcription factor, as in 
Ubc9 mutants nuclear Dorsal is high and the Toll pathway upregulated, resulting in 
overproduction of hemocytes (Chiu et al., 2005; Huang et al., 2005).
Mutations in smt3 (SUMO) and Iwr (E2) genes have shown that SUMOylation is 
essential for viability. Zygotic smt3 mutant animals (Drosophila SUMO) are reported 
to die at the early second instar stage (Nie et al., 2009). Germline clones that remove 
maternal deposition of Smt3 resulted in failure to hatch for more than 70% of embryos 
and those that hatched died as first instar larvae (Nie et al., 2009). Also, RNAi knock 
down of SUMO (smt3) in the prothoracic gland showed that SUMOylation is required 
for metamorphosis. Knock-down animals exhibited prolonged larval life and inability 
to form pupa due to inefficient production of Ecdysone (Talamillo et al., 2008b).
Ubc9 (Iwr) has various reported alleles that generate different phenotypes. One class 
of mutations (semi) that are caused by P-element insertions results in late embryonic or 
first instar larval lethality (Epps and Tanda, 1998). The phenotype is attributed to the 
inability of maternal transcription factor Bicoid to enter the nuclei during embryogene- 
sis. Another class of alleles contains Iwr4'3, which was generated by P-element exci­
sion, and Iwr5, which comes from a point mutation. Both of these alleles are recessive 
lethal and they are able to suppress chromosome non-disjunction mutation during 
meiosis (Apionishev et al., 2001). These alleles also complement the semi alleles in
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/ ?complementation tests. A different study reports a molecular null Iwr allele that de-
/ 3letes the entire Iwr locus (Xiuli, 2003). The homozygous Iwr die at the early third in­
star larval stage, and based on genetic evidence the Iwr4'3 and Iwr5 alleles are classified
/ ?as hypomorphs, as the trans-heterozygous animals with Iwr die at the middle and late 
third instar larval stage respectively (Xiuli, 2003).
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METHODS AND MATERIALS
Fly strains
The UAS-RNAi transgenic stocks for the aosl and uba2 were obtained from Droso­
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phila Genetic Resource Center (DGRC) in Kyoto. The UAS-RNAi lines for ubc9 
(Iwr) were obtained from Vienna Drosophila RNAi Center (VDRC). The UAS-RNAi 
for smt3 was kindly provided by Dr. Barrio (Talamillo et al., 2008b). Bloomington 
Stock Center was the source for the PBac-element insertion line in aosl (aosl17744) 
and for the P-element insertion that was used to generate the uba2 alleles.
Mosaic analysis
The mitotic clones were generated with the MARCM system. Female flies of the geno­
type: hs-flp, UASsrcEGFP; actGal4, UASGFP; FRT82BGal80 were crossed with male 
flies: 1) FRT82B, 2) FRT82Bao,s7'™/ TM6B, 3) \JASaosl; FRT82Baosl17744/ 
TM6 C, 4) UASp35; FRT82B and 5) UASp35; FRT82B a o sl'77441TM6 C for genera- 
tion of GFP+ clones that are wild type, aosl mutant, cDNA-rescued aosl mutant, p35- 
expressing wild type and p3 5-expressing aosl mutant respectively. The progeny of 
each cross were heat shocked for 1 h at 37°C, about 48 hours after egg lay. The heat- 
shock induced expression of Flipase facilitates the mitotic recombination of the two 
FRT containing chromosome arms. The daughter cell that will obtain 2 copies of 
Gal80 will not express the UASGFP and UASsrcEGFP transgenes, as Gal4 will be in­
hibited by Gal80. The daughter cell that will obtain 2 copies of the non Gal80 FRT 
chromosome, and therefore it will have the desired genotype, it will be marked with 
the expression of GFP and will give rise to GFP+ clone cells after subsequent divi­
sions. The larvae were dissected at late third instar larval stage, 2.5-3 days after heat 
shock. For the p3 5-expressing aosl mutant clones, the larvae were dissected at differ­
ent time points (2.5-3.5 days after heat shock) in order to image the mutant cells in 
various steps of delaminating process. In these experiments the time of heat shock 
changed accordingly.
46
The MARCM system was used also for the generation of the uba2 mutant clones. 
Female flies of the genotype: hs-flp, tubGal4, UASnlsGFP; FRT80BtubGal80 were 
crossed with male flies: 1) FRT80B, 2) FRT$0Buba2N2 / TM6 C and 3) UASuba2; 
FRT80Buba2N2 for generation of GFP+ clones that are wild type, uba2 mutant and 
cDNA-rescued uba2 mutant respectively. The clones are induced with heat shock of 
the progeny from each cross, 48 hours after egg lay. The larvae were dissected 2.5-3 
days after heat shock, at late 3rd instar larval stage.
The mitotic clones in the Minute background were generated using the hsFLP-FRT 
system. Female flies of the genotype hs-flp; FRT82B or hs-flp; FKY%2Baosl17744/ 
TM6B were crossed with males FRT82B, ubiGFP, RpS3plac92/ TM6 B for generation of 
GFP- clones that are wild type and aosl mutant respectively. The progeny of each 
cross were heat shocked for 1 h at 37°C, 4 days after egg lay (due to the developmental 
delay of Minute animals). The larvae were dissected 2.5 days after heat shock.
Plasmid construction
pBluescript SK+ -Aosl
The plasmid was generated in order to be used for in vitro translation of aosl and 
probe preparation for in situ hybridization. The cDNA clone LD33652 of aosl was di­
gested with SacI-PstI and the aosl coding region fragment was cloned into SacI-PstI 
digested pBluescript vector, in orientation that T3 promoter of pBluescript vector 
would produce a sense RNA probe while T7 promoter would produce an antisense 
probe.
CMC105-<ms7 surrounding sequence
This plasmid was constructed in order to disrupt and replace aosl gene with homolo­
gous recombination. The first and most of the second exon of aosl was designed to be
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deleted and therefore, the sequence that was cloned in order to be used for homologous 
recombination was upstream and downstream of the potential lesion. The upstream se­
quence of the targeted aosl region, which is extended up to the neighboring gene, was 
amplified with primers that contained restriction enzyme sites in their 5’ end. The F 
primer contained a Spel site and the R primer contained an Avrll site.
5’ CCGACTAGTGAAACTGGTAATAGGTGCG F 
5’ CGCCTAGGACGCCTTTTGAAAATG R
After restriction enzyme digest, the amplified DNA sequence was cloned into a di­
gested Spel-Avrll CMC 105 vector.
In a second step, the CMC 105-upstream sequence plasmid was used as a vector for 
cloning the downstream sequence of the targeted aosl region, which contained the 3 rd 
exon of aosl, part of the second exon and some of the neighboring gene sequence. The 
region was amplified with primers that contained Nhel restriction site at their 5’ ends. 
5’ CGAGCTAGCTGACACCATTTGCCG F 
5’ CGAGCTAGCGCGAAATAAGTCGGC R
After restriction enzyme digest, the amplified DNA sequence was cloned into a di­
gested Nhel CMC 105 vector-upstream sequence plasmid. Diagnostic digests allowed 
the distinction of clones that has the insert in the correct orientation.
pUAST AttB-Uba2 cDNA
This plasmid was used in order to make transgenic flies that express Uba2 under Gal4 
driver control. The cDNA clone LD22577 of uba2 was digested with Bglll-Xhol and 
the uba2 cDNA was cloned into Bglll-Xhol digested pUAST AttB vector.
t>Ca4-AttB-Uba2 genomic region
The uba2 genomic region construct was used to rescue the uba2 mutant phenotype. 
The cloned genomic sequence included the uba2 locus and the surrounding upstream
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and downstream sequence up to the middle of the neighboring genes for each side. The 
genomic sequence was amplified with primers that contained restriction sites in the 5’ 
end: F primer contained a PstI site and the R primer contained an Xbal site.
5’ GCGCT GC AGT C AC AT ACCT ATCCG 3’ F 
5’ CGTCTAGAAAGTGGAGCCAGGCGT 3’ R
After restriction enzyme digest, the amplified DNA sequence was cloned into a digested Pstl- 
Xbal pCa4-AttB vector.
In situ hybridization in larvae using RNA probe (Patel protocol)
1. Third instar larvae from w1118 fly stock were dissected in lxPBS (137mM NaCl, 2.7 
mM KC1,10.14mM Na2HP(>4, 1.03 mM KH2PO4). The anterior half of the larval body 
was inverted and the fat body was removed.
2. The dissected larvae were fixed with 4 % PFA in lxPBS, for 20 min at Room Tem­
perature.
3. Then, the larvae were rinsed in methanol 2-3 times.
4. Rehydration of the larvae followed, through rinses with different concentration of 
Methanol and PT (lxPBS, 0.2% Triton).
7 parts ME/ 3 parts PT 5 min at RT
5 parts ME/ 5 parts PT 5 min at RT
3 parts ME/ 7 parts PT 5 min at RT
FP (4% PFA in PT) 5 min at RT
5. Pretreatment.
a) 3 washes of the larvae for 5 min each in PTw (1 xPBS, 0.1% Tween-20) on a rotator 
at Room Temperature
b) 1 wash of the larvae in Detergent/Tween-20 solution (1% SDS, 0.5% Tween-20,
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50mM Tris-HCl pH 7.5, ImMEDTApH 8.0 and 150mMNaCl) for 30 min on a rota­
tor at RT
c) 1 wash of the larvae for 10 min in a 1:1 mix of SDS-Hyb (50% formamide, 5x SSC, 
1% SDS and 0.1% Tween-20) and Detergent/Tween-20 on a rotator at RT
d) 1 wash of the larvae for 10 min in SDS-Hyb on a rotator at RT
e) Prehybridization in SDS-Hyb (+hs DNA) for about lh  at 65°C with agitation.
For 10 ml SDS-Hyb solution, 100 pi herring sperm DNA (from lOmg/ml stock) were 
added. The DNA was added after boiling it for 10 min to denaturate it.
6 . Hybridization
RNA probe was diluted (1:25 to 1:200) in SDS-Hyb that had herring sperm DNA. 
The dilution varies depending on how strong is the signal that probe produces.
The diluted probe was boiled for 10 min and then cooled on ice.
The prehybridization buffer from larvae was removed and 100-200 pi of diluted probe 
per sample were added. The larvae were incubated in hybridization buffer overnight at 
65°C.
7. Washes
a) 2 washes of the larvae for 20 min each in SDS-Hyb at 65 °C with agitation.
b) 2 washes of the larvae or 20 min each in 50 % SDS-Hyb /50 % Detergent Tween at 
65 °C with agitation.
c) 2 washes of the larvae for 20 min each in 20 % SDS-Hyb /80 % PTw at 65 °C with 
agitation.
d) 2 washes of the larvae for 20 min each in Undiluted PTw at 65 °C with agitation.
e) 2 washes of the larvae for 20 min each in PT on a rotator at RT
8. The alkaline phosphatase conjugated anti digoxigenin antibody was diluted at 
1:2000 in PT. The larvae were incubated with 200-400 pi of the diluted antibody solu­
tion on a rotator for 2 h at RT.
9. 4 washes of the larvae for 20 min each in PT on a rotator at RT
10. 3 washes of the larvae for 5 min each in AP buffer (5mM MgCL, lOOmM NaCl, 
lOOmM Tris-HCl pH 9.5 and 0.1% Tween-20) on a rotator at RT.
11. The larvae were incubated in dark with 0.5-1 ml BCIP/NBT solution (6 .6  pi NBT 
and 3.3 pi BCIP/ ml AP) after the last wash with AP buffer. When the larvae were 
stained enough, the reaction was stopped by washing with PBS several times.
12. The tissues were mounted in 70 % glycerol in PBS.
Protein extraction from larvae and Western blot analysis
1. Every time, fresh lysis buffer was prepared: lx RIPA (Pierce) in which lx  protease 
cocktail and PMSF in final concentration ImM were added. PMSF is not stable in non 
organic solution for more than 30 min, so it should be placed last, just before the be­
ginning of dissection. After preparation, the lysis buffer was placed on ice and it was 
divided to aliquots in different tubes (depending on the number of the samples).
In the case of a-SUMO Western blot, the lysis buffer that was used contained also 
NEM (TV-Ethylmaleimide, SIGMA) protease inhibitor in final concentration lOmM, so 
that the SUMO deconjugation will be prevented. NEM was added also in the PBS so­
lution that was used during dissection of larvae.
2. Larvae were dissected in lxPBS (or lxPBS + NEM). The anterior half of the body 
was inverted. The fat body and salivary glands were removed. In those samples that 
were wild type but needed to be compared with the mutant larvae samples, the imagi- 
nal discs were removed as well. The trachea, brain and cuticle were kept in all sam­
ples.
3. Each dissected larva was placed immediately in the tube with the lysis buffer. The 
lysis buffer was kept on ice all the time. The number of dissected larvae in the lysis
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buffer depended on the needs of the experiment. Usually, high concentration protein 
samples have been prepared by placing 50 dissected larvae in 75 pi lysis buffer.
4. After finishing the dissection for each sample, a blue pestle was used to smash the 
larvae in the buffer. The grinding was continued till only the cuticle was remained.
5. The lysate was centrifuged in 15,700 x g at 4°C for 30min.
6 . Then the supernatant was transfered in a new tube and it was placed on ice.
7. Loading buffer was added before the samples were applied to protein gel.
4x loading buffer (0.2M Tris-HCl pH 6 .8 , 8% SDS, 40% glycerol, 10% BME, + 
Bromophenol Blue)
8 . The samples were stored at -80°C or directly applied to the gel
9. Pre-cast gels from BIORAD were used (4-15 % acrylamide gradient gels for the a- 
SUMO and a-Aosl Western blots and 7.5% acrilamide gels for the a-Uba2 Western 
blot).
10. For the blotting we used antiserum for SUMO, Aosl and Uba2 that were kindly 
provided by Dr. Griffith (Long and Griffith, 2000) and were used at 1:500,1: 5000 and 
1: 1500 dilutions respectively. The level of loaded protein in each gel lane was moni­
tored by re-blotting with an antibody for alpha-Tubulin (SIGMA) in 1:1000 dilution. 
The secondary antibodies, anti-Rabbit HRP (SIGMA) and anti-Mouse HRP (invitro- 
gen) were used at 1:20000 and 1:5000 dilutions respectively. The blots were devel­
oped in autoradiography film, after incubation with chemiluminescent substrate 
(SuperSignal West Dura PIERCE and Immun-Star HRP substrate kit BIORAD).
Immunostaining
1. The 3 rd instar larvae were dissected in lxPBS and the anterior half of the larval body
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was inverted.
2. The tissues were fixed in 4% PFA in lxPBS, for 20 min at RT.
3. After fixation, the larvae were washed 3 times with lxPBS
4. Incubation of the larvae in PBT (lxPBS, 0.2% Triton, 0.5% BSA) for lh  at RT with 
agitation.
5. The primary antibody was diluted in PBT and added in the larvae. Primary antibod­
ies that were used for immunostaining : anti-cleaved Caspase 3 (1:500), anti-Tubulin 
(1:1000), anti-Cyclin A (1:500), anti-Cyclin B (1:500), anti-Elav (1: 80).
The larvae were incubated with the primary antibody overnight at 4 °C.
6 . 3 washes of the larvae with PT (lxPBS, 0.2% Triton) for 10 min each at RT with 
agitation.
7. Incubation with the secondary antibody in dark for 2 h at RT
8 . 3 washes of the larvae with PT (lxPBS, 0.2% Triton) for 10 min each at RT with 
agitation.
9. Imaginal discs were removed and mounted in 70% glycerol in lxPBS 
Imaginal disc cell preparation for FACS
1.1.5 ml tubes were siliconized by adding 1.5 ml of sigmacote to the tubes for 5 min­
utes. Excess was removed and the tubes were left to air dry overnight.
2. Dissociation medium (90% lOx Trypsin-EDTA SIGMA, IX PBS, + 0.5 |ig/ml
i
Hoechst) was prepared and placed in a siliconized tube.
The medium was placed on ice and kept on ice throughout the dissection process.
3. Larvae were transfered from vial/bottle with forceps into a Petri dish or glass crys­
tallization dish. The larvae were rinsed with distilled water to remove food/yeast, then 
rinsed briefly with 70% EtOH, and after that rinsed twice with distilled water.
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4. Three drops of lx PBS were placed on a siliconized glass slide. In one drop the 
washed larvae were dissected. The anterior half of the larva was inverted and stripped 
of fat body and gut. Then the anterior half was transferred to the second drop, using 
forceps, to dissect away the wing imaginal discs, excluding other tissues e.g. other 
discs, trachea. Finally, the discs were transferred to the third drop to wash them of re­
sidual media (yeast) and larval tissues. In the third drop, using a needle the imaginal 
discs were cut in 3-4 pieces.
5. The cut discs (piles of 6-10 cut discs) were transferred into the dissociation medium 
via a 2 0 ul micropipettor which has been coated with protein and fat from the dissected 
larvae by pipetting up and down the liquid from the first drop. Each sample contained 
about 40 discs.
6 . When all the discs were collected and placed into the medium, the tube was re­
moved from the ice and placed on rotator at room temperature. Dissociation was al­
lowed to occur for ~1.5 h. Every 20 minutes, the medium was agitated by briefly 
vortexing (no more than 2  seconds).
7. Finally, the tube was removed from the rotator, placed on ice, and passed to the Cy­
tometry facility for FACS analysis.
dsRNA knock-down in S2 cells
For the aosl dsRNA knock-down two different gene regions were targeted. Using the 
LD33652 cDNA clone of aosl as template, the two different region of aosl were am­
plified with primers that contained a T7 promoter sequence in their 5’ end:
5 ’ T AAT ACGACT C ACT AT AGGGAC AGTT GGC AGC ACT GATT C 3’ aosl FI 
5» TAATACGACTCACTATAGGGCAGAGGTCTTCTCCTTCAAG 3 'aosl R1 
5’ T AAT ACGACT C ACTAT AGGGGCGACC AACG AGG AACT GTT 3’ aosl F2
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5 ’ TAATACGACTCACTATAGGGTAGAGCTTCGTCGCCCAGTA V aosl m  
The PCR products were purified and they were used as a template for in vitro transla­
tion with the Ambion Megascript T7 kit. The produced RNA was purified with 
RNeasy kit. Next, Tris-HCl pH 7.5 in final concentration lOmM and NaCl in final 
concentration lOOmM were added in the purified RNA in order to achieve the correct 
salinity and pH, and therefore to avoid osmotic reaction when RNA is added to the S2 
cells. The two strands of RNA were annealed by incubation in 95 °C for 5 min and 
then cool down at RT for lh.
The same process was followed for the production of dsRNA that targets smtS. The 
gene region was amplified from the cDNA clone LD07775 with the primers:
5’ TAATACGACTCACTATAGGGTTTGACCACTTAGCAGCTTCAACAA 3’ smt3 F 
5 ’ T AAT ACGACT C ACTAT AGGGACC ATTTT CTT GT CT GC AAAT G 35 smt3 R 
For negative control, we generated dsRNA from the pMT vector backbone sequence.
Prior to the knock-down experiment, the S2 cells were split to 1 million /ml and 
kept in 10% Fetal Bovine Serum (FBS) containing medium (Schneider’s Drosophila 
medium). Two days later, the cells were split again to 2 millions /ml in S2 medium 
that had no serum. The cells were then placed in 6 -well plates (1 ml per well) and they 
were left to attach to the bottom of the well for 20 min. After 20 min, 1 ml of 20% se­
rum containing medium was added in each well. Immediately afterwards, the dsRNA 
was added in the cells (~10 pg in each well that contained 2 millions of cells). Every 
second day the dsRNA is renewed through the course of the knock-down treatment. 
The cells were collected at various time points and after cell lysis, the extract was ex­
amined through Western blot analysis in order to confirm the effect of knock-down in 
the protein levels.
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Chapter 1
17744Analysis of the aosl allele and generation of additional 
alleles
The aosl17744 mutation
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In contrast with other genes of the SUMOylation pathway, the biological role of 
aosl in Drosophila has not been studied (Talamillo et al., 2008a), probably due to the 
unavailability of aosl mutations. At the beginning of this work, the only publically- 
available putative aosl mutation was a PiggyBac transposable element insertion in the 
5’UTR of the aosl gene, 41 bp before the ATG (Fig 6 A). This transposable element 
mutation {aosl17744) was one of several that were generated by the Drosophila gene 
disruption project (Thibault et al., 2004). The project’s goal was the generation of gene 
mutations throughout the genome using transposable elements. The aosl17744 insertion, 
although it was not a mutation in the coding region of aosl gene, caused elimination of 
the imaginal structures from developing larvae, an interesting phenotype that drew our 
attention to further analysis.
Phenotypic description of the aosl17744 mutants
Flies that carry the aosl17744 mutation as heterozygotes do not exhibit any obvious 
mutant phenotypes in the external adult cuticular structures or viability. However, the 
homozygous mutant animals die at the early pupal stage. Pupation in these animals 
generally occurs after a significant developmental delay compared with wild type ani­
mals (see graph in 1.8). The mutant pupae die before any adult structures are formed.
At the 3 rd instar larval stage the homozygous mutants completely lack the entire set 
of imaginal discs. In Figure 6B the expression of Histone 2A-RFP fusion protein in 
wild-type animals illuminates the imaginal discs, which are characterized by high nu­
clear density and therefore easily distinguished from the larval cells. In contrast, we 
did not observe intense RFP staining in the anterior portion of aosl17744 homozygous 
mutant larvae, indicating the absence or severe reduction of imaginal disc structures.
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Another feature of the aosl17744 phenotype was the size difference of the CNS in the 
mutant animals. The CNS of the homozygous mutant larvae was smaller than compa­
rable wild-type controls. Staining with Phalloidin that labels F-Actin at the cell cortex 
showed that the size difference was due to the loss of the optical lobes in the mutant 
CNS (Fig 6C, 6C’).
A PBac insertion
Figure 6
In a o sl17744 mutant larvae, imaginal discs and optic lobes o f CNS are absent.
A . The aosl gene model. The PBac transposable element that causes the a o s l17744 phenotype is 
inserted in the 5’UTR o f aosl gene.
B. Histone 2A-RFP expressing larvae. The imaginal discs in the wt 3rd instar larvae are visualized 
due to high nuclear density o f these tissues. In contrast, the imaginal discs are absent in homozy­
gous a o sl17744 mutant larvae.
C  a n d  C \  The CNS of wt and mutant larvae stained with phalloidin. The mutant CNS is smaller 
than the wt due to the loss o f optic lobes.
Lastly, we observed that melanotic tumors often appear within homozygous mutant 
larvae, although not in every animal. The melanotic tumor formation has been reported 
to take place in Iwr mutant animals as well (Huang et al., 2005). Strikingly, apart from
59
the defects in the imaginal discs and CNS, there was no other obvious growth pheno­
type in the rest of the larval organs and tissues.
Rescue experiments confirm aosl17744 to be an aosl allele
In order to confirm that the aosl17744 transposon insertion mutation was an actual al­
lele of aosl, various rescue experiments were performed. First, complementation tests 
with deficiencies that span the aosl genomic region showed that the lesion responsible 
for the imaginal disc elimination phenotype resides in the chromosomal location of 
aosl. Furthermore, precise excision of the PBac transposable element completely res­
cued the lethality and the growth defect in imaginal discs and CNS of the aosl17744 
mutant animals (Fig 7A). This result indicates that the phenotype of the aosl17744 ho­
mozygous mutants was most likely caused by the PBac insertion in the aosl gene.
Finally, in order to verify that loss of aosl caused the lethality and growth pheno­
types, a genomic rescue construct was designed. The genomic rescue construct in­
cluded the aosl gene region and the flanking upstream and downstream genomic 
sequence, extended to the half part of each of the neighboring genes (Fig 7B). One 
copy of this genomic construct was sufficient to rescue the lethality and growth defects 
of the homozygous mutant animals (Fig 1C).
In summary, by showing that: 1) The aos17744 insertion failed to complement 
chromosomal deficiencies in the aosl region; 2) That excision of the PBac element re­
verted the aosl17744 phenotypes; and 3) That a small genomic fragment containing only 
the complete aosl gene could rescue all phenotypes associated with the PBac inser­
tion, these experiments confirm that the aosl17744 transposable element mutation is an 
aosl allele.
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Figure 7
Rescues experiments confirmed a o sl17744 mutation as an aosl allele.
A. The precise excision of the PBac transposable element is confirmed by PCR amplification. The 
primers bind on each side of the insertion site, so that the reaction produces a DNA band only 
when the transposable element is removed. The DNA that is amplified from the excision lines has 
the same size with the wt and thus the PBac is excised without altering the surrounding genomic 
sequence.
B. The Aosl genomic construct includes the aosl gene region and its flanking sequence till the 
middle o f the neighboring genes.
C. The graph shows the % of a o s l17744 homozygous adult flies and the % of a o sl17744 homozygous 
adult flies with at least one copy of the Aosl genomic construct that survive. The percentage for 
the a o s l17744 is 0% as the homozygous animals die as early pupae. The percentage o f rescued mu­
tant flies is very close to what is expected according to the Mendelian ratio for homozygous ani­
mals (1/3, as the homozygous balancer animals die at very early stage). Therefore, the rescue is 
complete.
aosl is broadly expressed, but at variable levels in different tissues
The aosl17744 homozygous mutant animals primarily died at the pupal stage. At the 
3rd instar larval stage the only affected tissues were the imaginal discs and CNS. This 
was surprising as the Aosl/Uba2 complex is known to be the only El SUMO activat-
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ing enzyme in the organism and the El activity should be required for all SUMOyla- 
tion events (Johnson, 2004). It is also evident from the literature that SUMOylation 
takes place in all tissues and at all developmental stages (Geiss-Friedlander and Mel­
chior, 2007). Therefore, it was unexpected that aosl mutant animals did not exhibit 
more severe phenotypes, such as lethality in earlier developmental stages or defects in 
all or in the majority of larval tissues due to problems with cell viability or homeosta­
sis.
As a starting point to understand the phenotype, aosl expression levels were exam­
ined in different tissues. In situ hybridization showed that aosl mRNA was expressed 
in the nurse cells of the ovaries and was maternally deposited in the embryo (Fig 8A). 
This observation is consistent with the results of other studies, which show that there is 
maternal deposition for all the SUMO pathway enzymes (Hashiyama et al., 2009). 
Later in embryogenesis the expression of aosl becomes restricted to the CNS and the 
gonads (BDGP expression data). In 3rd instar larvae, high levels of aosl expression 
were observed in the imaginal discs and the CNS (Fig 8B, 8C). The rest of the ante­
rior-half larval tissues that were used for in situ hybridization (trachea, larval epider­
mis, salivary glands) did not exhibit strong aosl expression. However, Western blot 
analysis showed that there was aosl expression in these tissues as well (see below in 
Fig 11) but probably in lower amounts that were not detected by in situ hybridization.
The maternal deposition of aosl mRNA in aosl17744 mutant embryos could explain 
the survival of the mutant animals through the early developmental stages. When ma­
ternal aosl was eliminated by generation of aosl17744 germline clones in adult females, 
the embryos failed to hatch (data not shown). In the 3rd instar larval stage, aosl seems 
to be expressed more in imaginal discs and the CNS, the same tissues that have growth 
defects in aosl17744 mutant animals. However, the rest of the larval tissues where aosl 
is expressed at lower levels do not exhibit any phenotype. One possibility is that
aosl17744 was not a null allele, and thus the Aosl protein still produced in the mutant 
animals was sufficient for viability of tissues that do not require high levels of A osl.
Figure 8
In situ hybridization shows the aosl expression 
A  a n d  A ’, antisense and sense probe respectively. 
The aosl is expressed in the nurse cells o f the 
ovaries and transferred to the egg.
B  a n d  B \  The expression o f aosl is ubiquitous in 
the imaginal discs. The sense probe in the B’ is used as a signal specificity 
control.
C. The expression of aosl in the CNS is intense in certain zones. There is 
strong expression in the optic lobes, structures that are absent in aosl mu­
tant animals.
aosl transcription is detected in aosl17744 mutant larvae
The aosl17744 allele is caused by a PBac transposable element insertion in the 5 ’UTR 
of aosl, so it does not physically disrupt the coding region of the gene. In order to test 
whether aosl gene function is abolished by the PBac insertion, the aosl mRNA pres­
ence in the mutant larvae was examined by RT-PCR. A pair of primers was designed 
to amplify part of the aosl transcript sequence. As a control for genomic DNA pres­
ence in the sample, a second pair of primers was used to amplify sequence that ex­
tended from aosl to the neighboring gene (Fig 9A). The result showed that aosl 
mRNA was still detected in the mutant larvae, although in lesser amounts than were 
observed in the wild-type animals (Fig 9B).
The presence of aosl mRNA in mutant animals implies that some functional Aosl
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protein could still be produced in aosl17744 mutant larvae. Indeed, the Pbac insertion is 
in the 5’ UTR and there is no direct interruption of the aosl coding region. If some 
functional protein is still produced in the mutants, then aosl17744 is not a null allele, 
and a true null allele of aosl could be expected to cause a more severe phenotype in 
larva development. To address these issues would require the generation of additional 
alleles of aosl and observation of the resulting phenotypes.
PBac insertion
CG5844
FR1 eos1 transcript fargm ent--------------  549bp
FR2 Genomic DNA control --------------------------------1 1 48bp
wild type a o sl17744
FR1 FR2 FR1 FR2
1 Kb 
500bp
Figure 9
aosl transcript can be detected in a o s l17744 mutant animals with RT-PCR.
A. For the RT-PCR, two primers that bind in the coding region o f aosl gene were designed. As a 
control for genomic DNA presence in the RNA samples, a second PCR reaction was set with a 
reverse primer that binds to the neighboring gene.
B. The aosl transcript is still present in the mutant sample, although it is less than the wild type 
(FR1 lanes). There is no genomic DNA contamination in either wt or mutant sample (FR2 lanes). 
This means that the PCR product in the FR1 lanes is amplified from transcript only and not from 
genomic DNA.
It is worth mentioning here that transheterozygotes carrying aosl17744 over defi­
ciencies spanning the aosl genomic region did not exhibit more severe phenotypes 
than the aosl17744 homozygous mutant animals alone. This shows that further reduc­
tion of Aosl protein has no additional effect in the phenotype. However, a complete 
elimination of Aosl protein would be more conclusive about its function in fly devel­
opment.
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Identification of new aosl alleles by TILLing
In order to identify new alleles for aosl, the Seattle fly TILLing service was used. 
The fly TILLing service includes the screening of a large collection of mutagenized 
fly strains for mutations in a gene of interest; stocks of candidate mutations are then 
provided to the user for further analysis. The fly stock library consists of balanced 
lines that carry homozygous viable EMS mutations in the second and third chromo­
some, but in fact theses lines carry a lot more mutations (some of them recessive le­
thal) that have accumulated in the flies over time.
For the identification of mutations the genomic DNA of each line is isolated and 
mixed in pools of 8. The mixed DNA is used as a template for PCR amplification of 
the gene of interest with 5’ end labeled primers. The PCR products are denatured and 
annealed so that the wild-type products will form double strands with the products that 
carry a gene mutation. The mismatches that are formed between the wild type and mu­
tant strands are then recognized and cleaved by a single strand endonuclease. The de­
natured products of the endonuclease digestion are subsequently analyzed with gel 
electrophoresis. The pools that contain mutations for the gene exhibit more DNA 
bands in the gel that are of smaller size than the control. Then the DNA of the individ­
ual lines of these pools is analyzed separately in order to identify the mutant line and 
finally the mutation is sequenced and mapped (Winkler et al., 2005).
Many point mutations were acquired for the aosl gene through TILLing. Eleven of 
those point mutations resulted in amino acid substitutions and two of them in a pre­
mature stop codon (Table 1). Complementation tests with the aosl17744 allele and with 
deficiencies that span the aosl gene were performed in order to identify which of these 
new mutations were aosl alleles. Unluckily, we found that all of the newly identified- 
mutations complemented the aosl17744 and the deficiencies, except one.
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' The Q303* stop codon mutation failed to complement both the aosl17744 and two 
independent deficiencies. The animals that carried the Q303* mutation over aosl17744 
or the deficiencies died as 3rd instar larvae or early pupae. Interestingly, those larvae 
had no imaginal discs and the CNS size was smaller than wild type, which is exactly 
the phenotype of the aosl17744 homozygous mutant animals. This could mean that the 
30 amino acids that are missing from the C-terminal of the truncated Aosl protein are 
important for the protein function or that the pre-mature stop codon results in nonsense 
mediated decay of the aosl mRNA (Nicholson and Muhlemann, 2010).
Unfortunately, although aoslQ303* was found to be an aosl allele, the mutation was 
located in a degenerate TM6B balancer that lost the Tb marker, instead of the non­
balancer chromosome which made it unsuitable to use for further studies. Also, an­
other putative stop codon mutation, W29*, which was expected to cause a similar phe­
notype with aosl17744 and aosl®303* mutations, 
complemented the deficiencies and aosl17744, Se­
quencing of the W29* line DNA showed that in 
fact there was not any mutation in the aosl gene 
and that the TILLing service sent the wrong fly 
stock. The correct fly stock was never found, as 
the genomic DNA isolate that was used for 
screening by Tilling had taken place a long time 
ago and the corresponding stock had likely been 
mislabeled or lost in the meantime.
Generation of aosl null alleles by homologous recombination (Golic method)
As the TILLing service did not result in finding an aosl null allele that could be used
ami no acid 
substitution
Stop codon 
mutations
G46E W29*
V74I Q303*
Q82H
G153D
V181I
P202L
Q204K
V207M
R227Q
G235S
V296I
Table 1.
aosl mutations that were identified 
by Tilling
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for further analysis, another approach was used to obtain it. In order to knock out the 
aosl gene by homologous recombination, the ends-out targeting method that was de­
veloped by Kent Golic and his group was applied (Gong and Golic, 2003).
The procedure of this method starts with the design and construction of a plasmid 
that includes the gene targeting homologous sequence flanking the mini white marker 
gene. The vector that was used (CMC 105) had already the mini white gene, one mul­
tiple cloning site at each end of the gene, one FRT sequence at the external end of each 
multiple cloning site and two P-element ends that flank all the above sequences. Ap­
proximately 1.7Kb of the genomic sequence upstream of aosl (starting from the 
5’UTR of aosl) and about 1.8 Kb of the genomic sequence downstream of aosl (start­
ing from the middle of the second exon of aosl) were cloned at the 5’ and 3’ ends of 
mini white gene respectively. The cloning design was such that the first and most of 
the second exon of aosl would be deleted and replaced by the mini white gene (Fig 
10 A).
In order to ensure also that no Aosl protein would be produced after gene replace­
ment, the ATG and some of the 5’ UTR sequence of aosl was also omitted from the 
plasmid, and we confirmed that the remaining aosl gene coding sequence could not 
provide any open reading frame for Aosl.
Importantly, since the genomic sequence that was cloned in the plasmid contained 
the neighboring genes of aosl, the amplification of these regions was performed by a 
proof-reading polymerase so that no mutations in those genes would be induced by the 
homologous recombination. The cloned regions of the targeting plasmid were se­
quenced to confirm that there were no changes in the sequence during amplification.
The rest of the procedure for gene targeting was performed by Genetic Services, Inc. 
(Cambridge, MA). Briefly, the targeting plasmid was injected into fly embryos along 
with a helper plasmid encoding Transposase, and the P-element containing all of the
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described sequences was thus inserted into the fly genome. Several transformant lines 
were obtained. These flies were subsequently crossed with flies that carry hsp70-FLP 
and hsp70-ISeel, and the progeny were heat shocked. The activated FLP in the prog­
eny excises the target sequence-mmz white cassette as a circular DNA fragment and the 
I Seel enzyme digests the circular DNA into a linear fragment. This is possible be­
cause there is a unique I Seel restriction site between the FRT sequence and the multi­
ple cloning site upstream of the mini white gene. The linear DNA can then integrate 
into the genome after recombination with the homologous genomic sequence, thereby 
replacing the endogenous aosl gene.
The flies that emerge from this cross were selected based on the presence of mini 
white. The adults that have white or mosaic eyes are those in which the insertion has 
been excised and possibly reintegrated in the genome of some cells, while the colored 
eyed animals are those in which the insertion was not excised. Females with white or 
mosaic eyes, that hopefully carry some oocytes with reintegrated insertions, were 
crossed with males that express FLP constitutively to remove the initial insertion from 
the progeny so that only the reintegrated insertion will remain. The progeny of this 
cross were then selected for colored eyes and the individual males were crossed with 
white females for balancing and validation.
aosl null alleles are obtained with homologous recombination (Golic method)
We obtained nine potential “aosl knockout” males from the Genetic Services, Inc. 
Fly lines were established after balancing the progeny of each of those males. Most of 
the lines were homozygous viable and complemented our original aosl17744 allele. 
Some lines were homozygous lethal but they also complemented aosl17744^ indicating 
the insertion disrupted a different gene. Fortunately, two lines that were homozygous
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lethal failed to complement the aosl17744 allele. Strikingly, the homozygous animals of 
these lines die at the 3rd instar larval stage, they lack imaginal discs and have a smaller 
CNS (Fig 10B).
In order to confirm the disruption of aosl in the new alleles, genomic DNA from 
homozygous mutant animals was isolated and the aosl genomic region was amplified 
by PCR and sequenced. Sequencing confirmed that both alleles have the correct gene 
sequence flanking the mini white insertion and therefore the aosl gene is deleted in the 
way it was designed. In addition, one copy of the aosl genomic construct was suffi­
cient to rescue the lethality and growth defects of the homozygous mutant animals, 
verifying that the new mutations acquired with homologous recombination are real 
aosl alleles.
The new aoslGollc1'2 alleles exhibit the same growth phenotype as aosl17744\ the 
imaginal discs were missing in homozygotes and the CNS was smaller than the wild- 
type. Thus, although the aosl gene was deleted in the new alleles, the phenotype of the 
homozygous mutants was not more severe than the aosl17744 mutants. The only clear 
difference in phenotype was limited to the fact that aoslGohc1,2 mutants do not form 
pupae and they die as 3rd instar larvae, after a larval wandering period that lasted for 
about 10 days (Fig 10C). In contrast, the aosl17744 mutant animals formed pupae after 
a significant developmental delay (Fig 10C) and they mostly died as early pupae and 
rarely as 3rd instar larvae. The inability of aosl mutants to pupate normally is consis­
tent with the reported requirement for SUMOylation in metamorphosis and in produc­
tion of ecdysone (Talamillo et al., 2008b).
This slight difference in phenotype between the aosl alleles was not reflected in the 
Aosl protein levels, since Western blot analysis showed Aosl to be absent from all 
mutant alleles (Fig 11). The absence of Aosl protein indicates that even aosl17744 is a 
very strong allele of aosl and equivalent in regard to imaginal disc growth to the
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Figure 10
a o slGol,c1’2 and a o sl17744 mutant animals exhibited similar phenotypes
A. The deletion o f aosl gene by homologous recombination (Golic method). The part o f 
the gene that is deleted is the second half o f the 5’ UTR, the first exon and half o f the sec­
ond exon.
B. The phenotype o f aosl mutant larvae for the different aosl alleles. The top panel shows 
Histone2-RFP expressing 3rd instar larvae. In the wild type larvae the imaginal discs are 
visible while in the a o s l17744 and ao s lGohc1,2 mutants the discs are absent. The bottom panel 
shows the phalloidin stained CNS o f 3rd instar larvae for the different genotypes. The optic 
lobes are missing in all aosl mutants. It seems also that the ventral cord of the CNS o f mu­
tant animals is longer than the wild type.
C. The formation o f pupa for the different aosl alleles. 4 days after the egg lay approxi­
mately 60 larvae for each genotype were transferred in a new vial and the pupa formation 
was monitored. We considered that pupa was formed when brown cuticle was generated by 
the animals (after the pre-pupal stage). The aoslGol,c1'2 mutant larvae failed to form pupae 
and they die as 3rd instar larvae about 15 days after the egg lay. In two cases the a oslGo ,cl'2 
mutant larvae generated cuticle only in the anterior body part, however these were counted 
as formed pupae (blue on day 7, green on day 10). The a o s l17744 mutant larvae form pupae 
between day 8 and 10 after the egg lay. The a o s l17744 mutants exhibit a significant devel­
opmental delay compared with the wild type animals that form pupae at day 5 and 6 after 
the egg lay.
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aoslGollc1, alleles. However, only aoslGohcl and aoslGohc2 can be considered null al­
leles, since the aosl gene is deleted, no protein is detected, and a slightly more severe 
phenotype is observed.
Figure 11
The Aosl protein levels in the aosl mutant animals are monitored by western blot analysis. The 
larvae were dissected and the upper half o f the body was used for protein extraction. The imaginal 
discs were removed from the wild type larvae so that the amount o f protein in the wt sample will 
be comparable with the mutant ones, since the mutant larvae have no discs. The Aosl protein is 
eliminated from all aosl mutant alleles. a-Tubulin is used for loading control.
Note here that in the wild type sample that has no imaginal discs there is significant amount of 
Aosl protein, which comes from epidermis, trachea, muscles etc. In these tissues Aosl protein is 
present although in situ hybridization could not detect aosl expression. This inability to detect 
aosl expression is probably due to limited sensitivity o f the in situ hybridization technique.
Returning back to the initial question that led us to the generation of aosl null alleles, 
it is still not clear how the elimination of Aosl, which is necessary for all SUMOyla- 
tion events in the organism, disrupts only a subset of cells in developing Drosophila 
larvae. A possible explanation may be that requirements for Aosl are bypassed in the 
cells because Uba2, the other subunit of El SUMO activating complex, is still present. 
Although it is known that Aosl and Uba2 participate in 1:1 ratio in the El complex 
(Long and Griffith, 2000), there is one study in yeast where it is observed that Uba2 is 
capable of interacting with itself (Dohmen et al., 1995). In this way, Uba2 could possi­
bly provide the cells with activated SUMO that is sufficient for their survival. In order 
to test this possibility, it was essential to obtain uha2 mutant animals and examine 
their phenotype in parallel with aosl.
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Chapter 2
Generation of uba2 alleles and double aosl, uba2 mutant 
animals.
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Generation of new uba2 alleles with imprecise P-element excision
For the uba2 gene there are no available mutations. In the 5’ end of uba2 there are 
two EP transposable element insertions, but none of them affects the uba2 gene and 
both are homozygous viable. However, these P-elements could be used to generate 
uba2 mutations by imprecise excision. The P-element insertion that was used for this 
purpose was P{EP}G4672, which is located in the 5’ UTR of the uba2 gene (Fig 12).
Uba2 g en o m ic  c o n stru c t 
4 3 6 5  bp
P { E P }G 4 6 7 2
Figure 12
The uba2 gene model. The transposable P-element that was used for imprecise excision is lo­
cated in the 5’UTR o f the uba2 gene. For the genomic rescue o f the uba2 alleles that were ob­
tained from the excision, a genomic construct was designed to include the uba2 gene region and 
the flanking sequence up to the 1/3 of the neighboring genes.
The fly lines that were acquired from the imprecise excision of the P-element were 
screened for lethality in homozygous animals. In this way our search was directed to 
the identification of strong uba2 alleles. After isolating lethal excision lines, five puta­
tive uba2 alleles were tested for the complementation of deficiencies that span the 
uba2 gene region. Three of the lines failed to complement the deficiency.
In order to distinguish which of these three fly lines carried a mutation in uba2 gene 
from those that carried mutations in other genes covered by the deficiency, we gener­
ated transgenic strains carrying an uba2 genomic rescue construct. The genomic rescue 
construct included the uba2 gene region and the flanking upstream and downstream 
genomic sequences, including half of each of the genes immediately neighboring uba2 
(Fig 12). The presence of one copy of this genomic construct was sufficient to rescue
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the lethality of two of the three excision lines that failed to complement the deficiency. 
Thus, two new uba2 alleles were obtained.
Interestingly, the homozygotes of both uba2 mutants died as early pupae. At the 3rd 
larval instar stage, the imaginal discs were missing and the CNS was smaller than that 
of wild-type controls. The phenotype of the uba2 mutants was therefore identical to 
that of the aosl17744 mutant animals and the aoslGollc1,2 mutants, with the exception of 
pupa formation.
Molecular characterization of the uba2C3 and uba2N2 alleles
The two new alleles, uba2cs and uba2m were examined in order to verify the muta­
tion in the uba2 gene. The uba2 genomic region of the mutants was amplified by PCR 
and sequenced. For both alleles the DNA fragment that was amplified by PCR had a 
bigger size than the control. This was an indication that the P-element was not excised 
completely and that some part of the transposon still remained in the genome. Se­
quencing showed that the uba2 sequence was unaltered in any of the mutants, except­
ing the site of the P-element insertion in the 5’UTR of uba2. Thus, the excisions 
removed only internal parts of the P-element, leaving the uba2 sequence intact. Never­
theless, this sequence rearrangement within the P-element was enough to cause uba2 
malfunction and produce a phenotype similar to aosl mutants. Therefore, since the 
coding region of uba2 is not affected, there is probably a defect in the transcription or 
the translation of uba2 in these mutants.
XT'}
To test this hypothesis, the transcript levels of uba2 in uba2 and uba2 mutant 
larvae were examined with RT-PCR. In both mutants uba2 transcript was detected, al­
though there was an obvious decrease in the transcript level compared with the control 
wild type animals (Fig 13 A). In order to test whether the residual uba2 transcript was
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translated, the Uba2 protein levels were examined. Western blot analysis showed that 
Uba2 protein was eliminated in both mutants (Fig 13B). These results indicate that 
uba2 and uba2 are both very strong alleles of uba2, if not null. The fact that the 
uba2 homozygous mutants can form pupae like the aosl17744 mutants, makes it likely
n  ai')that the uba2 and uba2 are not null alleles of uba2 in the same way that that 
aosl17744 is not null allele of aosl. However, in terms of larval growth and develop­
ment of imaginal structures, all the aosl and uba2 mutants obtained are identical in the 
phenotype they produce.
y\
wt ubaT0* uba21*2 
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Figure 13
The uba2 transcript and protein levels in uba2 mutant animals were monitored with RT-PCR 
and Western blot analysis respectively.
A. RT-PCR showed that there is still uba2 transcript in uba2cs and uba2m  mutants, although the 
transcript levels in both are decreased compared with the wild type. The DNA that is amplified 
in the RT-PCR is coming from transcript only and not from genomic DNA, because in that case 
the amplified fragment will have a bigger size as it will include the introns.
B. Western blot analysis was applied to monitor the Uba2 protein levels in the uba2 mutant 
animals. The protein extract o f dissected larvae was used for the blot. The imaginal discs from 
the wild type larvae were removed so that the wt sample will have comparable protein amount 
with the mutant ones which have no discs. The blot showed that Uba2 is eliminated form both 
uba2C3 and uba2N2 mutants and therefore the transcript detected by RT-PCR in the mutant ani­
mals probably is not translated.
Generation of double aosl, uba2 mutant animals
uba2 mutant animals exhibited the same growth phenotype in imaginal structures as
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aosl mutants. In order to exclude the possibility that Aos 1 and Uba2 can partially sub­
stitute for each other, a double aosl, uba2 mutant was generated by recombination of 
the aoslGobcl allele with the uba2N2 and uba2cs alleles. The double mutants that were 
obtained for all combinations of the above alleles had the same essential phenotype as 
the single mutants: the absence of imaginal discs in the homozygous larvae, a reduced 
CNS, and lethality at the 3rd instar larval stage. Hence, the phenotype of aoslGollc1'2 
null mutant animals was not enhanced by removal of Uba2. Consequently, the hy­
pothesis that the aosl mutants have a defect in only a subset of larval tissues because 
Aosl requirement could be bypassed with Uba2 presence is incorrect.
Global SUMOylation is severely reduced / eliminated in the mutant animals
The aosl and uba2 mutant larvae have the same phenotype, which is not enhanced in 
the aosl, uba2 double mutant animals. This finding is not only consistent with equal 
roles of Aosl and Uba2 in the El SUMO activating enzyme, but it also unexpectedly 
indicates that the El complex is not required in every tissue. Therefore, either SU­
MOylation is not required in every cell of the organism or there is an alternative SU­
MOylation pathway that does not require Aosl or Uba2 activity. In order to examine 
whether there is still SUMOylation in the mutant larvae, the global SUMOylation lev­
els were monitored by Western blot analysis.
For these experiments, 3rd instar larvae were collected from all different mutant lines
/ /1Rand w as control. The anterior halves of dissected larvae were used for protein ex­
traction in all cases. In the control sample, the imaginal discs were removed so that the 
amount of protein would be equivalent with the mutant ones in which the imaginal 
discs were absent due to loss of the El complex components. Western blots of these 
protein extracts with anti-SUMO antibodies showed that the global SUMOylation in
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aosl mutants, uba2 mutants and aosl, uba2 double mutants was nearly eliminated 
when compared with that in the wild type animals. Consistent with a failure to conju­
gate SUMO to substrates in the El complex mutants, we also observed that the free, 
unconjugated SUMO (approximately 15kD) was visibly increased (Fig 14). Also, 
these blots showed no major difference in SUMOylation levels between the different 
mutant genotypes, as all of them had the same reduction in bulk SUMOylation.
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Figure 14
Western blot analysis showed that global SUMOylation in all mutants is severely reduced. At 
the same time the free, unconjugated SUMO is increased in the mutants compared with the wild 
type sample from which the imaginal discs are removed. The wt sample with the imaginal discs 
has more total protein and probably that is the reason that the free SUMO is more than the wt 
sample which has no imaginal discs.
These results confirm that if any of the El SUMO activating enzyme subunits is 
absent then the enzyme is not functional (Johnson et al., 1997). The requirement of 
both El subunits is also confirmed by the fact that the same phenotype is produced by 
the aosl and uba2 mutations and the double aosl, uba2 mutants. Secondly, these re­
sults verify that the El SUMO activating enzyme composed by the Aosl/Uba2 het­
erodimer is required for all SUMOylation events. The residual SUMOylation signal
anti-SUMO
♦-free SUMO
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that is observed in the mutants could be just non specific binding of the antibody. Al­
ternatively, it could be SUMOylation that is facilitated by Aosl/Uba2 protein of ma­
ternal origin that has remained in the animals. Even in the cases of the aoslGollcl and 
aoslGollc2 null alleles where there is no zygotic aosl protein, there is still the possibility 
of residual El activity provided by maternal protein. Last but not least, this result indi­
cates that in those tissues where there is no obvious phenotype after Aosl/Uba2 re­
moval, the global SUMOylation is severely reduced or eliminated. Strikingly, and 
unexpectedly, the elimination of bulk SUMOylation did not seem to affect either the 
homeostasis or survival of these cells.
In summary, it seems that SUMOylation is primarily required in only some cell 
types in developing larvae. Thus, the next experimental step was to understand the rea­
son that these cells require SUMOylation more than other cells. For this purpose, the 
phenotype of imaginal disc cells upon the absence of Aosl and Uba2 was examined.
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Chapter 3
Phenotypic analysis of aosl and uba2 mutant cells in the 
imaginal discs
4 ?
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Mosaic analysis of aosl and uba2 mutant mitotic clones indicates that mutant 
imaginal disc cells die through apoptosis
In the homozygous aosl and uba2 mutant 3rd instar larvae the imaginal discs are 
absent, preventing further analysis. In order to analyze the phenotype of the mutant 
imaginal disc cells in greater detail, the induction of mitotic clones with the hsFLP- 
FRT system was used (Golic, 1991). In particular, the MARCM technique was applied 
(Lee and Luo, 2001), so that the mutant clones could be distinguished by the expres­
sion of GFP.
a o s l17744 +
control clones a o s l17744clones UAS aosl clones
Figure 15
a o sl17744 mutant mitotic clones die through apoptosis.
A, B, C. Mitotic clones positively marked with GFP and stained with a-cleaved Caspase3 (apop- 
totic marker) and phalloidin (F-actin staining).
A’, B’, C \  Magnification o f the clones presented in A, B and C respectively. In the a o s l17744 
mutant clones cells (B ’) the Caspase3 activation all over the clone indicates that these cells are 
massively dying through apoptosis. In contrast, apoptosis takes place randomly in wild type 
clone cells and non clone cells of the disc epithelium (A’). The expression o f aosl cDNA in the 
mutant a o s l17744 cells rescues the lethality of these cells (C’)-
A” , B” , C” . The GFP channel shows the outline o f the mitotic clones in A ’, B’ and C \  The 
a o sl17744 mutant clone shown in B” is disintegrated as the cells are dying.
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Three days after induction, aosl17744 mutant clones in the wing imaginal disc epi­
thelium appeared to be disintegrated. Staining with anti-Cleaved Caspase 3 antibody 
showed that in aosl17744 mutant cells, Caspase 3 was activated and thus the cells were 
dying through apoptosis (Fig 15B). This phenotype was a consequence of the absence 
of Aosl protein, as the clone lethality was rescued by expression of the aosl cDNA in 
the mutant clones (Fig 15C).
uba2N2 +
control clones uba2N2 clones UAS uba2 clones
Figure 16
uba2m  mutant mitotic clones die through apoptosis similarly with the a o s l17744 mutant clones. 
A, B, C. Mitotic clones positively marked with GFP and stained with a-cleaved CaspaseS and 
phalloidin.
A’, B ’, C \  Magnification o f the clones presented in A, B and C respectively. The presence o f ac­
tivated Caspase3 in the uba2m  mutant clone cells indicates that these cells are dying through apop­
tosis (B ’). The clone cell lethality is rescued with the expression of the uba2 cDNA (C’).
A” , B” , C ” . The GFP channel shows the outline of the mitotic clones in A ’, B ’ and C \  The integ­
rity o f the uba2N2 mutant clone shown in B” is disrupted as the cells are dying.
Similarly, uba2N2 mutant clones were induced in the wing imaginal disc epithelium 
and it was observed that uba2N2 mutant cells were also dying through apoptosis (Fig
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16B). The lethality of these clones was fully rescued by the expression of the uba2 
cDNA (Fig 16C).
Expression of the p35 Caspase inhibitor in aosl17744 mutant disc cells reveals 
more m utant phenotypes
Since the aosl17744 mutant clone cells were dying through apoptosis, their phenotype 
could not be analyzed further. However, it is possible that there were more defects in 
those cells and apoptosis could be just a secondary consequence of these defects. In 
order to examine possible additional defects, the apoptosis in aosl17744 mutant cells 
was blocked by the expression of the p35 Caspase inhibitor (Best, 2008).
wild type+UASp35 clones aos117744+UASp35 clones
Figure 17
p35 expression in a o s l17744 mutant clones reveals morphological defects in the mutant cells.
A. GFP marked wild type clones that express p35 Caspase inhibitor in the wing disc. In the 
cross section the clone cells that extend from apical to basal side are shown.
B. a o s l17744 mutant clones that express p35 have aberrant morphology. In the cross section the 
a o s l17744 mutant cells are shown to be detached from the apical surface and dropped in the basal 
side o f the epithelium. Only thin membrane extensions from the mutant clones are still attached 
apically (white arrows).
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p3 5-expressing aosl17744 mutant clones exhibited clear defects in their morphology. 
The cell bodies were detached from the apical surface of the epithelium and moved to 
the basal side, leaving only one or two thin membrane extensions reaching the apical 
surface. (Fig 17). Close observation of these clones showed that this was an intermedi­
ate stage of the extrusion process, as the mutant clone cells gradually detached from 
the apical side and dropped basally until they finally extruded from the epithelial 
monolayer as cell clumps on the basal surface of the wing disc (Fig 18).
This morphological change could be an outcome of the triggered cell death, as the 
phenotype is very similar to what is observed in dying epithelial cells of vertebrates 
(Rosenblatt et al., 2001). In this study they show that actin-myosin contractility in the 
dying cell and its neighbors push the dying cell to extrude from the epithelium before 
its death can cause a gap or leakiness in the epithelial sheet. The Actin accumulation 
on the apical side of the p3 5-expressing aosl17744 mutant clones (Fig 13 A and A’) sug­
gests that this mechanism is also applied in Drosophila. In addition, Rosenblatt et al., 
(2001) show that the extrusion of dying cells precedes the Caspase activation and 
function, as Caspase inhibitors fail to prevent cell extrusion. This is true also for 
aosl17744 mutant cells, as p35 expression could not inhibit the extrusion of the clones.
As they age, p3 5-expressing aosl17744 mutant clones gradually disappear from the 
epithelium, which could mean that they still die eventually. Therefore, one possibility 
is that blockage of apoptosis by p35 expression is not complete and the cell death 
process is just delayed. An alternate explanation for the loss of p35-expressing aosl 
mutant clones is that they become completely extruded from the wing disc and then 
disperse within the larval body.
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Figure 18
p35-expressing a o s l17744 mutant clones gradually extrude from the epithelium 
A  a n d  A ’. Lateral side o f a GFP marked mutant clone in the leg disc epithelium. The actin 
cytoskeleton is stained with phalloidin and the nuclei with DAPI. The red channel is shown 
in A ’. There is an accumulation o f actin in the apical side of the mutant cells (white arrow). 
B , C , D , a n d  E . Cross section o f mutant clones in the wing disc epithelium. The apical sur­
face of the mutant cells shrinks giving a triangle-like shape to the clone (B). Subsequently 
the clone cells get detached form the apical surface and they sink basally causing engulf- 
ment in the epithelium (left white arrow in C). The mutant cells are moving to basal side 
leaving only thin membrane extensions to the apical surface (D). Finally, the clone cells get 
completely detached from the apical side and start extruding from the epithelial monolayer 
(E).
F  a n d  F \  Lateral view of a mutant clone that has extruded from the wing disc epithelium. 
The clone cells retain their polarity as the Discs Large protein o f septate junctions is still 
localized asymmetrically in the cell periphery with high accumulation in the surface that 
the mutant cells attach to each other (white arrow in F ’).
p35-expressing aosl17744 mutant clones exhibit cell cycle progression defects
Another interesting feature of the aosl17744 mutant cells in which apoptosis is 
blocked by the expression of p35 is that they exhibit impaired proliferation. As a re­
sult, the clones remain small in size but the cells themselves seem to be enlarged. In 
order to examine changes in the size and cell cycle profile of these mutant cells, the 
imaginal disc cells were dissociated and sorted by Fluorescent Activated Cell Sorting 
(FACS; Fig 19A).
FACS analysis showed that aosl17744 mutant cells accumulated at the G2/M phase 
(Fig 19B). The average cell size of these cells was also found to be larger than the 
wild-type control cells, but this was due to the high percentage of cells in G2/M, which 
skews the mean. Importantly, GFP+ wild-type cells that express p35 had no significant 
difference in their cell cycle profile compared with the GFP' wild type cells, indicating 
that p35 expression alone did not interfere with cell cycle progression (Fig 19B).
Intriguingly, the accumulation of aosl17744 mutant cells in G2/M suggests that the 
DNA replication during S phase can be accomplished in the absence of Aosl and con­
sequently in the absence of SUMOylation. In order to provide more evidence that this 
is true, DNA synthesis was examined in the salivary glands of aosl homozygous mu­
tant larvae. It is known that the cells in the salivary glands perform many endoreplica- 
tion cycles, which means that they replicate their DNA without subsequent mitosis 
(Edgar and Orr-Weaver, 2001). We observed that the salivary gland cells of aosl17744 
and aoslGollc1,2 mutant larvae were capable of incorporating EdU, confirming that 
DNA synthesis was not affected by loss of Aosl (Fig 19C).
Our findings on cell cycle progression defects in aosl mutant cells are consistent 
with reports on ubc9 (SUMO E2) mutant cells in yeast and zebrafish (Nowak and 
Hammerschmidt, 2006; Seufert et al., 1995). Removal of the E2 SUMO conjugation
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Figure 19
p35-expressing a o s l17744 mutant clone cells accumulate at the G2/M
A. Imaginal discs containing GFP marked p35-expressing wild type control clones and GFP 
marked p35-expressing a o s l17744 clones were treated with Trypsin to dissociate the cells. The dis­
sociated cells were also stained with Hoechst DNA dye and then they were sorted by FACS.
B. FACS was used to sort the disc cells based on GFP expression and DNA content. The clone 
cells that were marked with GFP expression represented only a small percentage o f the disc cells 
(6.25% and 3.62% for wt and mutant clones respectively in this example). Hoechst stain allowed 
cell sorting according to DNA content for each cell population and the distribution was modeled to 
calculate the percentage o f cells in the different cell cycle phases (bottom panels). The a o sl17744 
mutant cells exhibit an accumulation in G2/M (last panel), which is also obvious in the heat map 
above. The cell cycle profile o f the p3 5-expressing wild type clone cells is similar to the profile of 
the GFP- wild type non clone cells, indicating that p35 expression does not interfere with cell cy­
cle progression.
C. Salivary glands of wild type and a o s l17744 mutant larvae were incubated with EdU and stained 
with anti-Tubulin. The mutant salivary gland cells are capable o f incorporating EdU in their DNA 
suggesting that endoreplication cycles are not affected in the absence o f Aos 1.
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enzyme Ubc9 from yeast cells result in the accumulation of mutant cells in G2/M. 
Similarly, the ubc9 mutant cells in zebrafish accumulate in G2/M and a small percent­
age of them undergo a second round of DNA replication. Collectively these observa­
tions indicate that SUMOylation in vivo is required for cell cycle progression and 
particularly for the passage through mitosis.
Induction of aosl17744 mutant clones in Minute background could not rescue 
the lethality of mutant cells
The FACS analysis above showed that aosl17744 mutant cells have defects in cell 
cycle progression, raising the possibility that the apoptosis of these cells was due to 
cell competition, a phenomenon where slow-dividing cells are killed by their wild-type 
neighbors (Morata and Martin, 2007). In order to eliminate cell competition, aosl17744 
mutant cells were induced in a Minute /+ genetic background. Minute are a class of 
dominant mutations in the ribosomal protein encoding genes which cause a develop­
mental delay and slow cell division (Dunn, 1937; Lambertsson, 1998). The growth ad­
vantage of wild-type cells against the mutant clone cells is removed when the clone 
cells are surrounded with Minute -/+ cells instead of wild-type cells, leading to the al­
leviation of cell competition and subsequent apoptosis of the “weak” cells.
In the case of aosl17744 mutant clones, the Minute /+ background did not prevent 
apoptosis of the mutant cells. We observed that Caspase 3 was still activated in the 
GFP-negative mutant clones. In discs containing control clones in the same Minute 
background, we only observed activated Caspase3 in the Minute /+ cells, as the wild- 
type cells outcompeted them (Fig 20).
The reason that the aosl17744 mutant cell lethality was not rescued in the Minute ge­
netic background could be that: 1) Cell competition was not fully eliminated; or 2)
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aosl mutant cells are simply incapable of dividing and die as a cell-autonomous con­
sequence of this defect. In the first case, Minute/+ cells can still divide, though slowly, 
while in aosl17744 cell cycle appears to be blocked at G2/M and therefore Minute cells 
still have a growth advantage between the two cell populations. Alternatively, apop­
tosis may be triggered internally in the aosl17744 mutant cells as a result of the cell cy­
cle arrest. These two possibilities of internal or external trigger of apoptosis are not 
mutually exclusive, as both could take place at the same time in the aosl17744 mutant 
cells.
wild type clones aos 117744 clones
in Minute/+  background in Minute/+  background
Figure 20
wild type and a o sl17744 mutant clones in Minute/+ genetic background
The mitotic clones are marked with absence of GFP and the discs are stained with anti-cleaved
Caspase3 to monitor apoptosis.
A. In the wild type control clones the apoptosis is restricted to the Minute/+ neighboring cells 
(white arrows), as the wild type cells clone cells outcompete them.
B. In contrast, the a o sl17744 mutant clone cells are dying through apoptosis and therefore the 
lethality o f these cells is not rescued by the induction o f clones in Minute/+ genetic background.
Cyclin A and Cyclin B are stabilized in p35-expressing aosl17744 mutant clones
The accumulation of p3 5-expressing aosl17744 mutant cells in G2/M revealed by 
FACS analysis raised the question of what causes this defect in cell cycle progression. 
One possibility is that DNA damage activates the G2 checkpoint, as SUMOylation is
known to participate in DNA repair (Johnson, 2004) and its absence could affect the 
process of repair. The presence of double strand break foci in the mutant clones was 
examined by immunostaining with an antibody that recognizes the y-phosphorylated 
H2Av Histone variant (Madigan et al., 2002). The result was negative, as the number 
of double-stranded break foci that were detected in mutant cells was similar to that de­
tected in control wild-type clone cells (data not shown).
Subsequently, we examined the presence of mitotic Cyclins in the mutant cells, as 
the accumulation of these Cyclins is necessary for the G2/M transition and entry in mi­
tosis (Budirahardja and Gonczy, 2009). The p3 5-expressing aosl17744 mutant clones in 
the eye disc epithelium were used for this analysis. In the eye disc there is a distinct 
population of cells arrested in G1 (morphogenetic furrow). The morphogenetic furrow 
moves from the posterior to anterior side of the disc as a wave. In front of the morpho­
genetic furrow the cells divide in an asynchronous manner while behind the furrow the 
cells undergo one synchronous round of division and then they differentiate (Lee and 
Orr-Weaver, 2003). Therefore, the mitotic Cyclins are expressed on both sides of the 
morphogenetic furrow but not in the cells of the furrow itself (Fig 21 A). Thus, we used 
immunohistochemistry to test whether Cyclin A and Cyclin B were present in mutant 
clones cells within the morphogenetic furrow.
Control, wild-type clones found in the furrow did not express Cyclin A since they 
were arrested in G1 like their neighboring cells outside of the clone. In contrast, all 
aosl17744 mutant clones found in the furrow had high levels of Cyclin A in comparison 
with their neighboring wild type cells (Fig 21B). Similar results were obtained for Cy­
clin B expression, as half of the mutant clones in the morphogenetic furrow exhibited 
high Cyclin B levels (Fig 21C; n=6/12 clones in the furrow).
The presence of Cyclins A and B in the aosl17744 mutant clone cells confirms the 
FACS result, which showed that mutant cells accumulated at G2/M. Also, it indicates
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Figure 21
Cyclins A and B are stabilized in p35-expressing a o s l17744 mutant clone cells
A. Schematic representation o f the CyclinA and B expression in the eye imaginal disc. The morpho­
genetic furrow moves from the posterior to anterior o f the disc. In the furrow the cells are arrested in 
G1 and they do not express Cyclins. In the anterior side o f the furrow the cells are dividing asyn- 
chronously, while behind the furrow the cells complete one round of synchronous division and they 
differentiate. Therefore, expression o f Cyclins A and B can be detected in cells in both sides o f the 
furrow.
B. Left panels: GFP-marked, p35-expressing wild type and a o s l'7744 mutant mitotic clones in the eye 
imaginal disc epithelium. The discs are stained with anti-CyclinA (red). Middle and right panels: 
Magnification o f mitotic clones that are found in the mophogenetic furrow. The wild type clones 
crossing the furrow have no CyclinA expression. In contrast a o sl17744 mutant clones cells in the fur­
row have high CyclinA levels, as it is shown in the red channel on the right (yellow arrow). High 
CyclinA levels were observed in all a o s l17744 mutant clones in the furrow that were examined.
C. GFP-marked, p3 5-expressing wild type and a o s l17744 mutant mitotic clones in eye discs stained 
with anti-CyclinB (red). Similar to the observation for CyclinA, the a o s l17744 mutant clone cells in 
the furrow showed high levels o f Cyclin B (yellow arrow in the bottom right panel). Elevated Cy- 
clinB levels were detected in half o f the a o s l17744 mutant clones that were found in the furrow.
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that the limiting step for progression through mitosis in the mutant cells is not a lack of 
mitotic Cyclin accumulation. In contrast, the high levels of Cyclins A and B in aosl 
mutant cells suggest the stabilization of these proteins. In yeast, Ubc9 (SUMO E2) de­
pletion also causes the stabilization of type B Cyclins (Seufert et al., 1995), therefore 
our results suggest that the mechanism by which SUMOylation regulates cell cycle 
progression could be highly conserved.
The stabilization of Cyclins A or B can cause a delay/arrest in metaphase or ana­
phase respectively (Jacobs et al., 2001). However, no cells in metaphase or anaphase 
were observed in the aosl17744 mutant clones. This could mean that there are additional 
defects in those mutant cells which can cause cell cycle arrest before metaphase, and 
Cyclin A and B normal degradation would not rescue cell cycle progression. The iden­
tification of these possible additional defects in the aosl17744 mutant cells remains an 
open question.
SUMOylation pathway components are required in dividing but not differenti­
ated imaginal disc cells
The results obtained from the phenotypic analysis of aosl17744 mutant cells in the 
imaginal disc epithelium indicate that Aosl elimination caused a cell cycle arrest in 
G2/M. Thus, DNA replication (S phase) seems to be unaffected in the mutant clone 
disc cells. Consistent with this, DNA synthesis was normal in the salivary glands of 
aosl17744 homozygous mutant larvae. Thus, it is possible that Aosl and subsequently 
SUMOylation are not required in the endoreplicating cells, but only in the dividing 
cells. This could explain the fact that aosl and uba2 mutant larvae exhibit defects only 
in imaginal discs and the CNS which are composed of dividing cells, while the cells in 
the rest of larval tissues endoreplicate and they grow in size but they do not divide. It
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has been shown that several mutations that inhibit cell cycle progression cause late 3rd 
instar larval-early pupal lethality and defects in imaginal discs (Gatti and Baker, 1989). 
The fact that aosl and uba2 mutants exhibit a very similar phenotype implies that 
these genes function primarily in cell cycle progression.
If this is the explanation of the observed phenotype in aosl and uba2 mutants, it 
would imply that SUMOylation is not required for the survival or the homeostasis of 
non-dividing cells. In order to test this possibility, the effects of Aosl and Uba2 deple­
tion was examined in dividing and differentiated cells of the same tissue- the eye 
imaginal disc. The GMR-Gal4 driver was used for the expression of RNAi only in dif­
ferentiated cells of the eye disc (behind the morphogenetic furrow), and the Eyeless- 
Gal4 driver was used for RNAi expression in both dividing and differentiated cells of 
the eye disc.
Surprisingly, the knock down of aosl and uba2 in differentiated cells had no effect 
on the eye imaginal disc or adult eye formation, while the expression of the same 
RNAi lines with the Eyeless-Gal4 driver resulted in a dramatic reduction of the imagi­
nal disc size and subsequently in a small adult eye (Fig 22). In many cases the pheno­
type was so severe that there was no head formation and the adult flies never eclosed. 
We observed similar phenotypes following RNAi knockdown of ubc9 (SUMO E2) 
and even the sumo gene itself (Fig 22), indicating that disruption of proliferative 
growth but not cell viability is a common effect of disrupting the SUMOylation path­
way. Taken together, these results indicate that in vivo SUMOylation is primarily re­
quired for cell division and is dispensable for cell survival or homeostasis.
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GMRGal4- UAS EGFP eyelessGal4-UAS EGFP
Figure 22
RNAi knock down of the SUMOylation pathway components in the eye imaginal discs. 
The GMRGaM driver is expressed in the differentiated cells behind the morphogenetic furrow 
while the Eyeless Gal4 driver is expressed both in dividing cells in front o f the furrow and 
differentiated cells posterior o f the furrow. GFP marks the expression pattern of these Gal4 
drivers, as it is shown in control discs (top panels). The discs are stained with phalloidin (red) 
and anti-elav (blue)
Under the control o f GMRGaM driver the expression of RNAi that targets a o sl, uba2, ubc9 
and smt3 in the differentiated cells o f the eye disc has no effect in the imaginal disc or the 
formation o f the adult eye. In contrast, the same RNAi lines when they are expressed with 
EyelessGal4 they cause reduction in imaginal disc size which results in small adult eye as 
well. The phenotypic defects from the RNAi expression vary in severity which ranges from 
weaker eye size reduction to pupal lethality in cases that the whole head fails to form and the 
flies never emerge from pupa.
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Chapter 4
Cell cycle profile analysis in S2 cells upon aosl knock down 
with dsRNA
94
aosl knockdown in S2 cells eliminates Aosl protein but does not affect cell cycle 
progression
The analysis of the aosl mutant phenotype in vivo showed that Aosl is required 
for cell cycle progression in imaginal discs, and particularly for the passage through 
mitosis. In order to test whether Aosl (and subsequently SUMOylation) is required for 
cell division in every cell type, the effect of Aosl depletion on Schneider 2 (S2) cell 
culture was examined.
The knock down of Aosl in S2 cells was performed with two different non­
overlapping dsRNAs. In this way the phenotypic defects caused from possible off- 
target genes can be distinguished from the defects which are due to Aosl elimination 
and will be common in both dsRNAs. For negative controls, S2 cells were treated with 
dsRNA against a plasmid vector backbone sequence which does not interfere with any 
expressed gene in the cells.
The Aosl protein was gradually eliminated from S2 cells upon dsRNA treatment. 
On the second day of the knockdown experiment, Aosl protein levels were already 
dramatically reduced. By day 4, Aosl could not be detected (Fig 23A). The cell cycle 
profile of knocked-down S2 cells was analyzed by FACS at different time points. Sur­
prisingly, there was no significant difference between the cell cycle profile of the Aosl 
knockdown cells and the cell cycle profile of the control cells (Fig 23 B).
The dsRNA knock-down experiment suggests that cell cycle progression is not af­
fected by Aosl elimination in S2 cells. However, Western blot analysis showed that 
global SUMOylation levels were not changed significantly in the knock down cells, al­
though Aosl was reduced beyond detection (data not shown). Therefore, the unaf­
fected SUMOylation could account for the unaltered cell cycle profile of these cells. 
One possible explanation is that there is still remaining Aosl protein in knocked down
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cells that cannot be detected with Western blot, but it is sufficient for maintenance of 
SUMOylation.
day 2 day 3 day 4 day 5
J?*
jm m  <*-■** -------  —  ' • ]
* m m m  M  — i  —  M > i :
] anti Aosl 
anti-Tub
G 1 S  G2JM G 1 S  G 2 /M  G 1 S  G2JM G 1 S
■  control 
m dsRNAI 
□  dsRNA2
2 nd d a y  3 rd d a y  4 *  d a y  5th d a y
Figure 23
Aos 1 knock down in S2 cells
A . western blot analysis showed that <m?/knock down results in gradual elimination o f the Aosl 
protein. With both dsRNAs the Aosl protein is already reduced on day 2 of the experiment com­
pared with the control cells and it is undetectable on day 4 o f the dsRNA treatment. Tubulin is 
used for loading control.
B. FACS analysis o f the aosl knocked down cells in different time points o f the dsRNA treatment 
showed that, despite the absence o f Aos 1 protein, there is no significant difference in the cell cycle 
profile o f these cells compared with the control.
smt3 (SUMO) knockdown in S2 cells eliminated SUMO protein and caused cell 
cycle progression defects in more than one phase
Aosl knockdown had no effect on cell cycle progression of S2 cells, probably due 
to unaltered SUMOylation. For this reason, the smt3 gene was knocked down in order 
to reduce SUMOylation and observe the effect of this reduction in cell cycle profile of
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the knocked down cells.
The smt3 knock down by dsRNA reduces Smt3 protein and cause a blockage of 
cell cycle progression at the Gl/S transition in S2 cells (Nie et al., 2009). By using the 
same sequence of smt3 gene for the dsRNA knock down, we found that the Smt3 pro­
tein was significantly reduced after 3 days of dsRNA treatment (Fig 24A). FACS 
analysis of the smt3 knockdown cells at different time points showed that the cell 
populations in G1 and G2/M were increased, while the percentage of cells in S phase 
was decreased compared with controls (Fig 24B). The Smt3-depleted cells exhibited 
the same distribution pattern in the different cell cycle phases for all time points that 
were examined. The defect in cell cycle progression of the smt3 knocked down cells 
was also apparent in the cell number, which was reduced compared with the control 
cells.
In the previous study, the smt3 knocked down S2 cells are found to accumulate 
gradually in G1 which is consistent with cell cycle arrest in Gl/S (Nie et al., 2009). The 
reproduction of this result was not achieved, as in our hands both G1 and G2/M cell 
populations were retained while the number of cells entering the S phase was minimal. 
This suggests that lack of SUMOylation in S2 cells can cause cell cycle blockage in 
both Gl/S transition and passage through mitosis.
In summary, contrasting with imaginal disc cells which require SUMOylation only 
for the progression through mitosis, it seems S2 cells display an additional requirement 
of SUMOylation in the Gl/S transition. This could reflect a difference in the regula­
tion of cell cycle between cells in vivo and in cell culture condition. Nevertheless, a re­
quirement for SUMOylation in cell cycle progression seems to be common in different 
cell types and in vivo and in cell culture systems.
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Figure 24
Smt3 knock down in S2 cells
A . Western blot analysis showed that smt3 knock down upon dsRNA treatment of S2 cells results 
in reduction o f the conjugated and free Smt3 protein from day 3 o f the experiment.
B. FACS analysis o f the smt3 knock down cells was used in order to observe the effect on cell 
cycle progression of the depletion o f SUMOylation. In all different time points that were examined 
the smt3 knocked down cells exhibit an increase in the percentage of cell population in G 1 and 
G2/M phase compared with the control cells, while the cell population in S phase is almost elimi­
nated. This result suggests that the cell cycle progression in the smt3 knocked down cells is 
blocked both in G l/S  transition and in the passage through mitosis.
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SUMOylation and development
In the present study, the role of the Aosl/Uba2 El SUMO activating enzyme in de­
velopment of Drosophila was examined. We show that aosl and uha2 mutant animals 
exhibit late 3rd instar/early pupal lethality and a severe disruption of imaginal disc and 
optic lobe development. The aoslGollcI’2 null mutants also displayed an inability to 
form pupae, which is consistent with a proposed requirement for SUMOylation in 
metamorphosis (Talamillo et al., 2008b).
The relatively late lethality of the El enzyme mutant animals can best be explained 
by a maternal rescue during embryogenesis and by the fact that during larval develop­
ment cell proliferation is restricted to imaginal cells. It has been shown that there is 
maternal deposition for all the components of the SUMO conjugation pathway 
(Hashiyama et al., 2009), and the presence of SUMO conjugation machinery in the egg 
is required for early cell divisions in the embryo. Removal of maternal Smt3 with in­
duction of germ line clones, leads to embryonic lethality (Nie et al., 2009). We also 
observed that upon induction of aosl17744 germ line clones, the embryos failed to hatch 
(data not shown).
In early embryos, aosl transcript is ubiquitous due to maternal deposition. Later, 
aosl is expressed mainly in the CNS, in the ventral nerve cord, and in the gonads 
(BDGP expression data). Similarly, smt3 and uba2 are expressed primarily in CNS and 
gonads at late stage embryos (Hashiyama et al., 2009). At the 3rd instar larval stage, we 
observed that aosl is highly expressed in the imaginal discs and the CNS. Thus, aosl 
mutant animals exhibit defects in those tissues in which the aosl gene is most highly 
expressed. It is possible that there were defects in the gonads of the aosl mutant larvae 
as well, but these tissues were not examined closely. The tissues that were most 
strongly affected by loss of aosl (imaginal discs and CNS) consisted of proliferating
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cells, and we showed that aosl is indeed required for cell proliferation. In contrast, 
larval tissues comprised of non-diving, endoreplicating cells, were not affected by 
Aosl depletion.
Some mutations of Iwr seem to resemble the phenotype that is produced by aosl
1 ? / ?and ubal mutations. The Iwr /Iwr homozygous mutant animals and the trans­
heterozygotes Iwr4'3/ Iwr13 and Iwr5/ Iwr13 animals die at the third install larval stage 
(Xiuli et al., 2003). In contrast, the semi class of Iwr mutants die much earlier, at late 
embryonic or first instar larval lethality (Epps and Tanda, 1998). It is unclear though, 
how semi mutants and Iwr13, which is molecular null, have so different phenotypes.
Animals mutant for smt3 {Drosophila SUMO) are reported to die at the early second 
instar stage (Nie et al., 2009). Thus, mutations for smtS cause lethality in earlier devel­
opmental stages than the aosl and uba2 mutations. It is not clear what the reason for 
this difference is, but it could be due to differential protein perdurance. Smt3 maternal 
protein might decline faster than aosl or uba2, and thus the embryonic divisions in 
smt3 zygotic mutants are disrupted, leading to defects in later developmental stages. 
However, even in the case that maternal Aosl and Uba2 decline at the same rate as 
SUMO, limited Smt3 protein could lead to lower level of SUMOylation than limited 
aosl, as one molecule of the El enzyme could catalyze many SUMO conjugation re­
actions.
SUMOylation and cell cycle progression
We showed that aosl mutant imaginal disc cells arrest in G2/M using FACS analy­
sis (Fig 19). The accumulation of SUMOylation-deficient cells in G2/M has been ob­
served both in yeast and in zebrafish upon ubc9 depletion (Nowak and 
Hammerschmidt, 2006; Seufert et al., 1995). However it is not clear what causes the
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cell cycle arrest in G2/M in SUMOylation deficient cells. We examined the possibility 
that it is caused by DNA damage checkpoint activation, but H2Av loci were not ob­
served in aosl mutant cells (data not shown). Next, the activation of Cdkl as defined 
by the presence of mitotic Cyclins was tested. Both Cyclin A and Cyclin B were pre­
sent in aosl mutant cells (Fig 21). Similarly, in ubc9 (E2) mutant yeast cells mitotic 
Cyclins are stabilized (Ref). The effect of SUMOylation in degradation of mitotic Cy­
clins could be direct, but so far there is no evidence that Cyclins are modified by 
SUMO. In contrast, it is reported that Pdsl (securin) is also stabilized in Asmt3 or 
Aubc9 mutant yeast cells (Dieckhoff et al., 2004). Pdsl is an APC substrate like the 
mitotic Cyclins, and the same study shows that more APC substrates are stabilized in 
SUMOylation deficient cells. Thus, it seems that lack of SUMOylation affects APC 
mediated proteolysis. However, it is not known if any of the APC subunits are modi­
fied by SUMO, or if other factors that regulate APC activity need to be SUMOylated. 
In addition, we did not observe any metaphase arrest in aosl mutant disc cells, which 
indicates that there must be earlier defects in these cells apart from the inefficient deg­
radation of substrates by the Anaphase Promoting Complex.
The cell cycle arrest in G2/M that is observed in SUMOylation deficient cells indi­
cates that DNA replication can occur in these cells. In zebrafish, it is shown that a 
small percentage of mutant cells undergo one more round of DNA replication and they 
have 8n DNA content (Nowak and Hammerschmidt, 2006). In Uba2 depleted yeast 
cells also it is reported that about 10% of the mutant cells have two buds (Dohmen et 
al., 1995). Hence, it seems that some mutant cells upon blockage of progression 
through mitosis can re-enter the cell cycle without the previous completion of mitosis 
and become polyploid. These observations indicate that the rest of the cell cycle 
phases (but not mitosis) can be completed in the absence of SUMOylation. We also 
showed that endoreplication (S-phase progression) is not affected in larval cells of
aosl mutant animals. These results indicate that in Drosophila cell division, SUMOy­
lation is primarily required for G2-M progression.
In contrast, SUMO dsRNA knockdown in S2 cells results in cell cycle arrest at 
Gl/S, before they replicate their DNA (Nie et al., 2009). We were also able to confirm 
the Gl/S progression defect in S2 cells upon SUMO knockdown, with the exception 
that we observed G2/M progression defect in these cells as well. Surprisingly, this re­
quirement for SUMOylation in the Gl/S transition was not observed in vivo. One pos­
sible explanation is that cell cycle regulation by SUMOylation is different in S2 cells 
than in imaginal discs. An alternative explanation could be that SUMOylation is re­
quired for cell cycle progression through both S phase and mitosis, but there is a dif­
ferent threshold for each of them. S-phase, for example, could require lower levels of 
SUMOylation than mitosis. Thus, as the amount of Aosl protein declines in a mutant 
cell clone, the blockage at G2/M is the first to be met. Following this logic in whole 
mutant animals, endoreplication of larval cells could be sustained by minimal levels of 
maternal Aosl protein while the proliferating imaginal discs would require much 
higher protein levels in order to divide normally. In this scenario, depletion of SUMO 
itself in S2 cells probably leads to sudden drop of SUMOylation levels below the 
threshold requirement for both S phase progression as well as mitosis. Nevertheless, 
regardless of the specific cell cycle phase requirement, SUMOylation seems to be nec­
essary for the cell cycle progression both in vivo and in cell culture.
SUMOylation is required for dividing cells but it is probably dispensable for vi­
ability of non-dividing cells
Our results from mosaic analysis in imaginal discs indicate that aosl mutant cells 
exhibit cell cycle progression defects and they die through apoptosis (Fig 15). Similar
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observations are reported for the Inner Mass Cells in the mouse embryos that are Ubc9 
deficient (Nacerddine et al., 2005). Also, in yeast depletion of Aosl, Uba2 and Ubc9 
causes cell cycle arrest and ultimately lysis of the cells (Dohmen et al., 1995; Johnson 
et al., 1997; Seufert et al., 1995). It is therefore clear that proliferation is affected by 
disruption of the SUMOylation pathway through ablation of the El or E2 enzyme.
Given the broad range of functions for SUMOylation in previous studies, it was un­
expected that non-dividing cells were unaffected by the lack of SUMOylation in our 
experiments. Consistent with our findings, however, trophoblastic cells in ubc9 mutant 
mice embryos are viable and morphologically normal (Nacerddine et al., 2005). Fur­
ther, differentiation is not inhibited in ubc9 morphant zebrafish cells (Nowak and 
Hammerschmidt, 2006). In the Drosophila eye disc, we showed that GMR-expressing 
differentiated cells were not dying upon aosl-, uba2~, ubc9- and smG-targeting with 
RNAi (Fig 22), and these discs were able to form adult eyes that were indistinguish­
able from wild type. We obtained similar results when we used the Eval-Gal4 driver 
for the expression of aosl and uba2 RNAi in all differentiated neurons of the entire 
animal (data not shown). In addition, we showed that the endoreplicating larval cells in 
aosl and uba2 mutant animals were not affected by the loss of SUMOylation.
One possible explanation for the lack of observed phenotypes in non-dividing cells 
would be that the dividing cells dilute their supply of the enzyme more rapidly, mak­
ing them more sensitive to loss of pathway components. However, it is shown that 
proliferating tissues express higher amounts of the SUMO pathway enzymes, which 
would serve to compensate for the loss of original proteins through dilution and to fa­
cilitate cell division. In zebrafish, in situ hybridization showed that ubc9 is expressed 
ubiquitously at early embryonic stages but it is primarily expressed in proliferating tis­
sues at later developmental stages (Nowak and Hammerschmidt, 2006). Similarly, in 
Drosophila the expression of smtS and uba2 is higher the CNS and gonads in late em­
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bryonic stages (Hashiyama et al., 2009). Expression of aosl is also reported to be ele­
vated predominantly in the nervous system and gonads during late embryogenesis 
(BDGP database). Moreover, we observed using in situ hybridization that at the 3rd in­
star larval stage aosl is expressed mainly in imaginal discs and CNS, which are prolif­
erating tissues during larval development.
These results suggest that there is an increased production of the SUMO conjugation 
machinery in proliferating cells. This is also demonstrated in the eye disc, where the 
expression profiles of diving and differentiated cells were analysed by SAGE (Jasper 
et al., 2002). In this study, uba2 and ubc9 (Iwr) were found to be expressed differen­
tially in the eye disc cell populations. Specifically, uba2 is expressed about twofold 
more in proliferating cells than the GMR-expressing differentiated cells, and approxi­
mately fourfold higher than in differentiated photoreceptors that express sevenless. For 
ubc9 (E2), proliferating cells express about 3x higher levels compared with the GMR- 
expressing non-dividing cells, and ubc9 transcript is almost absent in the sevenless- 
expressing cell population (Jasper et al., 2002).
Thus, it seems that proliferating cells have a higher demand for SUMOylation than 
the differentiated cells and upon differentiation the production of SUMO pathway 
component declines. It is also possible that the SUMOylation-deprived cells stop di­
viding before they dilute the enzymes of SUMO pathway below the level that is found 
in differentiated cells. In contrast, it seems that the non-dividing cells can tolerate a re­
duction in SUMOylation. GMR-expressing differentiated cells in the eye disc did not 
die upon RNAi targeting of the SUMO conjugation machinery and they formed a nor­
mal adult eye (Fig 22). The larval tissues of aosl and uba2 mutant animals had se­
verely reduced SUMOylation compared with wild type larval cells, as shown by 
Western blot analysis (Fig 14). However, these cells could still endoreplicate and they 
sustained organismal survival and normal cellular homeostasis through a prolonged
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larval period, which in the case of aoslGollc1'2 mutant animals lasted for more than ten 
days (Fig IOC).
Taken together, our results combined with previous observations in Drosophila and 
other organisms suggest that SUMOylation is required for cell division and subse­
quently for survival in proliferating cells. Our studies also indicate that SUMOylation 
is probably not essential in non-mitotic cells, unless minimal SUMO conjugation is 
sufficient for all cellular functions. SUMOylation therefore is essential for organism 
viability, as without it proliferation is blocked and development cannot be completed, 
while for cell viability SUMOylation might be dispensable.
If SUMOylation is not absolutely required for cell viability or homeostasis, an ob­
vious question is why non-dividing larval cells still express SUMO pathway compo­
nents and retain SUMO-conjugation, as shown by Western blots (Fig 14). One 
possibility is that the presence of SUMOylation is important for the robustness of 
some processes in these cells. It is also possible that SUMOylation provides a safety 
mechanism for the cells upon environmental challenges. It has been shown that vari­
ous stresses increase SUMOylation levels (Bossis and Melchior, 2006) and that viral 
proteins can interfere with SUMO conjugation machinery (Chiocca, 2007). Thus, re­
taining low levels of SUMOylation could facilitate the rapid response of cells to 
changes in the conditions of environment or protect the cells against infections. How­
ever, further studies are required in order to understand the role of SUMOylation in 
cells under different environmental conditions.
Finally, the possibility that SUMOylation is required primarily in dividing cells 
could provide a new approach in the treatment of pathological conditions that are 
caused by uncontrolled cell proliferation, like cancer. Targeting and reducing SUMOy­
lation could prevent cell proliferation of malignant cells leaving unaffected the 
“healthy”, differentiated cells. This would be advantageous in comparison with drugs
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treatments that they generate severe side effects, for example, drugs that inhibit prolif­
eration through spindle formation and can also affect the structure of microtubules in 
other cells, such as neurons.
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